UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of |
1934 |
For the quarterly period ended March 31, 2013
OR
¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of |
1934 |
For the transition period from to
Assurant, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-31978 | 39-1126612 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
One Chase Manhattan Plaza, 41st Floor
New York, New York 10005
(212) 859-7000
(Address, including zip code, and telephone number, including area code, of Registrants Principal Executive Offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x
The number of shares of the registrants Common Stock outstanding at April 26, 2013 was 76,991,219.
ASSURANT, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013
Amounts are presented in United States of America (U.S.) dollars and all amounts are in thousands, except number of shares and per share amounts.
1
Consolidated Balance Sheets (unaudited) At March 31, 2013 and December 31, 2012 |
March 31, 2013 |
December 31, 2012 |
|||||||
(in thousands except number of shares and per share amounts) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available for sale, at fair value (amortized cost - $10,791,996 in 2013 and $10,728,714 in 2012) |
$ | 12,143,800 | $ | 12,171,638 | ||||
Equity securities available for sale, at fair value (cost - $403,954 in 2013 and $422,703 in 2012) |
475,765 | 475,806 | ||||||
Commercial mortgage loans on real estate, at amortized cost |
1,290,003 | 1,311,682 | ||||||
Policy loans |
52,939 | 52,938 | ||||||
Short-term investments |
239,782 | 300,925 | ||||||
Collateral held/pledged under securities agreements |
94,629 | 94,729 | ||||||
Other investments |
585,850 | 568,600 | ||||||
|
|
|
|
|||||
Total investments |
14,882,768 | 14,976,318 | ||||||
|
|
|
|
|||||
Cash and cash equivalents |
1,604,625 | 909,404 | ||||||
Premiums and accounts receivable, net |
890,900 | 830,027 | ||||||
Reinsurance recoverables |
5,866,488 | 6,141,737 | ||||||
Accrued investment income |
162,671 | 149,032 | ||||||
Deferred acquisition costs |
2,887,051 | 2,861,163 | ||||||
Property and equipment, at cost less accumulated depreciation |
250,481 | 250,796 | ||||||
Tax receivable |
9,167 | 32,740 | ||||||
Goodwill |
638,621 | 640,714 | ||||||
Value of business acquired |
59,943 | 62,109 | ||||||
Other intangible assets, net |
296,102 | 262,994 | ||||||
Other assets |
120,731 | 97,700 | ||||||
Assets held in separate accounts |
1,811,992 | 1,731,873 | ||||||
|
|
|
|
|||||
Total assets |
$ | 29,481,540 | $ | 28,946,607 | ||||
|
|
|
|
See the accompanying notes to the consolidated financial statements
2
Assurant, Inc. Consolidated Balance Sheets (unaudited) At March 31, 2013 and December 31, 2012 |
March 31, 2013 |
December 31, 2012 |
|||||||
(in thousands except number of shares and per share amounts) |
||||||||
Liabilities |
||||||||
Future policy benefits and expenses |
$ | 8,506,669 | $ | 8,513,505 | ||||
Unearned premiums |
6,174,246 | 6,192,260 | ||||||
Claims and benefits payable |
3,638,290 | 3,960,590 | ||||||
Commissions payable |
345,865 | 339,680 | ||||||
Reinsurance balances payable |
97,854 | 103,808 | ||||||
Funds held under reinsurance |
60,905 | 61,413 | ||||||
Deferred gain on disposal of businesses |
111,528 | 115,620 | ||||||
Obligation under securities agreements |
94,611 | 94,714 | ||||||
Accounts payable and other liabilities |
1,582,950 | 1,514,091 | ||||||
Deferred income taxes, net |
179,502 | 161,288 | ||||||
Debt |
1,670,523 | 972,399 | ||||||
Liabilities related to separate accounts |
1,811,992 | 1,731,873 | ||||||
|
|
|
|
|||||
Total liabilities |
24,274,935 | 23,761,241 | ||||||
|
|
|
|
|||||
Commitments and contingencies (Note 13) |
||||||||
Stockholders equity |
||||||||
Common stock, par value $0.01 per share, 800,000,000 shares authorized, 78,440,357 and 78,664,029 shares outstanding at March 31, 2013 and December 31, 2012, respectively |
1,478 | 1,474 | ||||||
Additional paid-in capital |
3,051,639 | 3,052,454 | ||||||
Retained earnings |
4,102,087 | 4,001,096 | ||||||
Accumulated other comprehensive income |
778,029 | 830,403 | ||||||
Treasury stock, at cost; 68,932,638 and 68,332,638 shares at March 31, 2013 and December 31, 2012, respectively |
(2,726,628 | ) | (2,700,061 | ) | ||||
|
|
|
|
|||||
Total stockholders equity |
5,206,605 | 5,185,366 | ||||||
|
|
|
|
|||||
Total liabilities and stockholders equity |
$ | 29,481,540 | $ | 28,946,607 | ||||
|
|
|
|
See the accompanying notes to the consolidated financial statements
3
Consolidated Statements of Operations (unaudited)
Three Months Ended March 31, 2013 and 2012
Three Months Ended March 31, | ||||||||
2013 | 2012 | |||||||
(in thousands except number of shares and per share amounts) |
||||||||
Revenues |
||||||||
Net earned premiums |
$ | 1,850,448 | $ | 1,777,061 | ||||
Net investment income |
165,985 | 172,295 | ||||||
Net realized gains on investments, excluding other-than-temporary impairment losses |
13,038 | 9,383 | ||||||
Total other-than-temporary impairment losses |
0 | (1,936 | ) | |||||
Portion of net loss recognized in other comprehensive income, before taxes |
0 | 97 | ||||||
|
|
|
|
|||||
Net other-than-temporary impairment losses recognized in earnings |
0 | (1,839 | ) | |||||
Amortization of deferred gain on disposal of businesses |
4,092 | 4,621 | ||||||
Fees and other income |
117,060 | 111,403 | ||||||
|
|
|
|
|||||
Total revenues |
2,150,623 | 2,072,924 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses |
||||||||
Policyholder benefits |
857,361 | 856,358 | ||||||
Amortization of deferred acquisition costs and value of business acquired |
382,789 | 341,758 | ||||||
Underwriting, general and administrative expenses |
688,971 | 610,084 | ||||||
Interest expense |
15,078 | 15,076 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
1,944,199 | 1,823,276 | ||||||
|
|
|
|
|||||
Income before provision for income taxes |
206,424 | 249,648 | ||||||
Provision for income taxes |
88,644 | 86,388 | ||||||
|
|
|
|
|||||
Net income |
$ | 117,780 | $ | 163,260 | ||||
|
|
|
|
|||||
Earnings Per Share |
||||||||
Basic |
$ | 1.47 | $ | 1.84 | ||||
Diluted |
$ | 1.46 | $ | 1.81 | ||||
Dividends per share |
$ | 0.21 | $ | 0.18 | ||||
Share Data |
||||||||
Weighted average shares outstanding used in basic per share calculations |
79,984,576 | 88,772,845 | ||||||
Plus: Dilutive securities |
962,073 | 1,296,252 | ||||||
|
|
|
|
|||||
Weighted average shares used in diluted per share calculations |
80,946,649 | 90,069,097 | ||||||
|
|
|
|
See the accompanying notes to the consolidated financial statements
4
Consolidated Statements of Comprehensive Income (unaudited)
Three Months Ended March 31, 2013 and 2012
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
(in thousands) | ||||||||
Net income |
$ | 117,780 | $ | 163,260 | ||||
|
|
|
|
|||||
Other comprehensive (loss) income: |
||||||||
Change in unrealized gains on securities, net of taxes of $26,304 and $(9,442), respectively |
(50,112 | ) | 18,196 | |||||
Change in other-than-temporary impairment gains, net of taxes of $(1,402) and $(1,596), respectively |
2,605 | 2,965 | ||||||
Changes in foreign currency translation, net of taxes of $2,564 and $(2,683), respectively |
(10,317 | ) | 14,741 | |||||
Amortization of pension and postretirement unrecognized net periodic benefit cost, net of taxes of $(2,934) and $(2,012), respectively |
5,450 | 3,738 | ||||||
|
|
|
|
|||||
Total other comprehensive (loss) income |
(52,374 | ) | 39,640 | |||||
|
|
|
|
|||||
Total comprehensive income |
$ | 65,406 | $ | 202,900 | ||||
|
|
|
|
See the accompanying notes to the consolidated financial statements
5
Consolidated Statement of Stockholders Equity (unaudited)
From December 31, 2012 through March 31, 2013
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income |
Treasury Stock |
Total | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||
Balance, December 31, 2012 |
$ | 1,474 | $ | 3,052,454 | $ | 4,001,096 | $ | 830,403 | $ | (2,700,061 | ) | $ | 5,185,366 | |||||||||||
Stock plan exercises |
4 | (4,081 | ) | 0 | 0 | 0 | (4,077 | ) | ||||||||||||||||
Stock plan compensation expense |
0 | 7,678 | 0 | 0 | 0 | 7,678 | ||||||||||||||||||
Change in tax benefit from share-based payment arrangements |
0 | (4,412 | ) | 0 | 0 | 0 | (4,412 | ) | ||||||||||||||||
Dividends |
0 | 0 | (16,789 | ) | 0 | 0 | (16,789 | ) | ||||||||||||||||
Acquisition of common stock |
0 | 0 | 0 | 0 | (26,567 | ) | (26,567 | ) | ||||||||||||||||
Net income |
0 | 0 | 117,780 | 0 | 0 | 117,780 | ||||||||||||||||||
Other comprehensive loss |
0 | 0 | 0 | (52,374 | ) | 0 | (52,374 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance, March 31, 2013 |
$ | 1,478 | $ | 3,051,639 | $ | 4,102,087 | $ | 778,029 | $ | (2,726,628 | ) | $ | 5,206,605 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
See the accompanying notes to the consolidated financial statements
6
Consolidated Statements of Cash Flows (unaudited)
Three Months Ended March 31, 2013 and 2012
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
(in thousands) | ||||||||
Net cash provided by operating activities |
$ | 51,681 | $ | 1,021 | ||||
|
|
|
|
|||||
Investing activities |
||||||||
Sales of: |
||||||||
Fixed maturity securities available for sale |
675,395 | 417,798 | ||||||
Equity securities available for sale |
59,160 | 50,373 | ||||||
Other invested assets |
11,496 | 6,797 | ||||||
Property and equipment and other |
42 | 1,811 | ||||||
Maturities, prepayments, and scheduled redemption of: |
||||||||
Fixed maturity securities available for sale |
204,783 | 290,834 | ||||||
Commercial mortgage loans on real estate |
37,662 | 15,789 | ||||||
Purchases of: |
||||||||
Fixed maturity securities available for sale |
(976,579 | ) | (739,677 | ) | ||||
Equity securities available for sale |
(42,363 | ) | (54,043 | ) | ||||
Commercial mortgage loans on real estate |
(17,328 | ) | (20,260 | ) | ||||
Other invested assets |
(22,510 | ) | (6,528 | ) | ||||
Property and equipment and other |
(11,712 | ) | (7,126 | ) | ||||
Change in short-term investments |
63,414 | 61,650 | ||||||
Change in policy loans |
(74 | ) | (46 | ) | ||||
Change in collateral held/pledged under securities agreements |
103 | 1,204 | ||||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
(18,511 | ) | 18,576 | |||||
|
|
|
|
|||||
Financing activities |
||||||||
Issuance of debt |
698,093 | 0 | ||||||
Change in tax benefit from share-based payment arrangements |
(4,412 | ) | (1,526 | ) | ||||
Acquisition of common stock |
(6,617 | ) | (103,629 | ) | ||||
Dividends paid |
(16,789 | ) | (15,941 | ) | ||||
Change in obligation under securities agreements |
(103 | ) | (1,204 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
670,172 | (122,300 | ) | |||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents |
(8,121 | ) | 805 | |||||
|
|
|
|
|||||
Change in cash and cash equivalents |
695,221 | (101,898 | ) | |||||
Cash and cash equivalents at beginning of period |
909,404 | 1,166,713 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 1,604,625 | $ | 1,064,815 | ||||
|
|
|
|
See the accompanying notes to the consolidated financial statements
7
Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
1. Nature of Operations
Assurant, Inc. (the Company) is a holding company whose subsidiaries provide specialized insurance products and related services in North America and select worldwide markets.
The Company is traded on the New York Stock Exchange under the symbol AIZ.
Through its operating subsidiaries, the Company provides debt protection administration, credit-related insurance, warranties and service contracts, pre-funded funeral insurance, solar project insurance, lender-placed homeowners insurance, renters insurance and related products, manufactured housing homeowners insurance, individual health and small employer group health insurance, group dental insurance, group disability insurance and reinsurance, and group life insurance.
2. Basis of Presentation
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements.
The interim financial data as of March 31, 2013 and December 31, 2012 and for the three months ended March 31, 2013 and 2012 is unaudited; in the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary to a fair statement of the results for the interim periods. The unaudited interim consolidated financial statements include the accounts of the Company and all of its wholly owned subsidiaries. All inter-company transactions and balances are eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the 2013 presentation.
Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. The accompanying unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Companys Annual Report on Form 10-K for the year ended December 31, 2012.
3. Recent Accounting Pronouncements
Not Yet Adopted
In July 2011, the Financial Accounting Standards Board (FASB) issued amendments to the other expenses guidance to address how health insurers should recognize and classify fees mandated by the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (together, the Affordable Care Act) in their statements of operations. The Affordable Care Act imposes an annual fee on health insurers for each calendar year beginning on or after January 1, 2014. The amendments specify that the liability for the fee should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense ratably over the calendar year during which it is payable. The guidance is effective for calendar years beginning after December 31, 2013, when the fee initially becomes effective. Therefore, the Company is required to adopt this guidance on January 1, 2014. The Company is currently evaluating the requirements of the amendments and the potential impact on the Companys financial position and results of operations.
8
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
4. Investments
The following tables show the cost or amortized cost, gross unrealized gains and losses, fair value and other-than-temporary impairment (OTTI) of our fixed maturity and equity securities as of the dates indicated:
March 31, 2013 | ||||||||||||||||||||
Cost or Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value | OTTI in AOCI |
||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
United States Government and government agencies and authorities |
$ | 520,252 | $ | 8,003 | $ | (170 | ) | $ | 528,085 | $ | 0 | |||||||||
States, municipalities and political subdivisions |
793,252 | 102,655 | (20 | ) | 895,887 | 0 | ||||||||||||||
Foreign governments |
647,656 | 73,235 | (1,559 | ) | 719,332 | 0 | ||||||||||||||
Asset-backed |
13,417 | 1,364 | (164 | ) | 14,617 | 1,155 | ||||||||||||||
Commercial mortgage-backed |
61,005 | 4,755 | 0 | 65,760 | 0 | |||||||||||||||
Residential mortgage-backed |
733,486 | 55,649 | (1,041 | ) | 788,094 | 16,247 | ||||||||||||||
Corporate |
8,022,928 | 1,116,344 | (7,247 | ) | 9,132,025 | 23,313 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total fixed maturity securities |
$ | 10,791,996 | $ | 1,362,005 | $ | (10,201 | ) | $ | 12,143,800 | $ | 40,715 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity securities: |
||||||||||||||||||||
Common stocks |
$ | 14,694 | $ | 6,750 | $ | 0 | $ | 21,444 | $ | 0 | ||||||||||
Non-redeemable preferred stocks |
389,260 | 67,265 | (2,204 | ) | 454,321 | 0 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity securities |
$ | 403,954 | $ | 74,015 | $ | (2,204 | ) | $ | 475,765 | $ | 0 | |||||||||
|
|
|
|
|
|
|
|
|
|
December 31, 2012 | ||||||||||||||||||||
Cost or Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value | OTTI in AOCI |
||||||||||||||||
Fixed maturity securities: |
|
|||||||||||||||||||
United States Government and government agencies and authorities |
$ | 633,329 | $ | 8,722 | $ | (127 | ) | $ | 641,924 | $ | 0 | |||||||||
States, municipalities and political subdivisions |
800,592 | 106,560 | (96 | ) | 907,056 | 0 | ||||||||||||||
Foreign governments |
672,671 | 82,096 | (1,359 | ) | 753,408 | 0 | ||||||||||||||
Asset-backed |
27,182 | 1,437 | (422 | ) | 28,197 | 1,159 | ||||||||||||||
Commercial mortgage-backed |
64,344 | 5,539 | 0 | 69,883 | 0 | |||||||||||||||
Residential mortgage-backed |
714,628 | 56,983 | (554 | ) | 771,057 | 14,259 | ||||||||||||||
Corporate |
7,815,968 | 1,193,695 | (9,550 | ) | 9,000,113 | 21,291 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total fixed maturity securities |
$ | 10,728,714 | $ | 1,455,032 | $ | (12,108 | ) | $ | 12,171,638 | $ | 36,709 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity securities: |
||||||||||||||||||||
Common stocks |
$ | 14,707 | $ | 4,243 | $ | 0 | $ | 18,950 | $ | 0 | ||||||||||
Non-redeemable preferred stocks |
407,996 | 53,976 | (5,116 | ) | 456,856 | 0 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity securities |
$ | 422,703 | $ | 58,219 | $ | (5,116 | ) | $ | 475,806 | $ | 0 | |||||||||
|
|
|
|
|
|
|
|
|
|
9
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Our states, municipalities and political subdivisions holdings are highly diversified across the United States, and Puerto Rico, with no individual states exposure (including both general obligation and revenue securities) exceeding 0.5% of the overall investment portfolio as of March 31, 2013 and December 31, 2012. At March 31, 2013 and December 31, 2012, the securities include general obligation and revenue bonds issued by states, cities, counties, school districts and similar issuers, including $166,703 and $168,705, respectively, of advance refunded or escrowed-to-maturity bonds (collectively referred to as pre-refunded bonds), which are bonds for which an irrevocable trust has been established to fund the remaining payments of principal and interest. As of March 31, 2013 and December 31, 2012, revenue bonds account for 52% of the holdings. Excluding pre-refunded revenue bonds, the activities supporting the income streams of the Companys revenue bonds are across a broad range of sectors, primarily highway, water, transit, airport and marina, higher education, specifically pledged tax revenues, and other miscellaneous sources such as bond banks, finance authorities and appropriations.
The Companys investments in foreign government fixed maturity securities are held mainly in countries and currencies where the Company has policyholder liabilities, which allow the assets and liabilities to be more appropriately matched. At March 31, 2013, approximately 67%, 16% and 6% of the foreign government securities were held in the Canadian government/provincials and the governments of Brazil and Germany, respectively. At December 31, 2012, approximately 67%, 15%, and 6% of the foreign government securities were held in the Canadian government/provincials and the governments of Brazil and Germany, respectively. No other country represented more than 3% and 5% of our foreign government securities as of March 31, 2013 and December 31, 2012, respectively.
The Company has European investment exposure in its corporate fixed maturity and equity securities of $1,121,187 with an unrealized gain of $116,993 at March 31, 2013 and $1,054,820 with an unrealized gain of $122,420 at December 31, 2012. Approximately 28% of the corporate European exposure is held in the financial industry at March 31, 2013 and December 31, 2012. Our largest European country exposure represented approximately 5% of the fair value of our corporate securities as of March 31, 2013 and December 31, 2012. Approximately 4% of the fair value of the corporate European securities are pound and euro-denominated and are not hedged to U.S. dollars, but held to support those foreign-denominated liabilities. Our international investments are managed as part of our overall portfolio with the same approach to risk management and focus on diversification.
The cost or amortized cost and fair value of fixed maturity securities at March 31, 2013 by contractual maturity are shown below. Expected maturities may differ from contractual maturities because issuers of the securities may have the right to call or prepay obligations with or without call or prepayment penalties.
Cost or Amortized Cost |
Fair Value | |||||||
Due in one year or less |
$ | 470,574 | $ | 478,172 | ||||
Due after one year through five years |
2,594,342 | 2,763,366 | ||||||
Due after five years through ten years |
2,767,739 | 3,008,642 | ||||||
Due after ten years |
4,151,433 | 5,025,149 | ||||||
|
|
|
|
|||||
Total |
9,984,088 | 11,275,329 | ||||||
Asset-backed |
13,417 | 14,617 | ||||||
Commercial mortgage-backed |
61,005 | 65,760 | ||||||
Residential mortgage-backed |
733,486 | 788,094 | ||||||
|
|
|
|
|||||
Total |
$ | 10,791,996 | $ | 12,143,800 | ||||
|
|
|
|
The following table summarizes the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Proceeds from sales |
$ | 776,670 | $ | 468,591 | ||||
Gross realized gains |
17,266 | 15,532 | ||||||
Gross realized losses |
5,205 | 6,569 |
10
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
The following table sets forth the net realized gains (losses), including OTTI, recognized in the statements of operations as follows:
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Net realized gains (losses) related to sales and other: |
||||||||
Fixed maturity securities |
$ | 13,687 | $ | 12,205 | ||||
Equity securities |
(387 | ) | (3,078 | ) | ||||
Other investments |
(262 | ) | 256 | |||||
|
|
|
|
|||||
Total net realized gains related to sales and other |
13,038 | 9,383 | ||||||
|
|
|
|
|||||
Net realized losses related to other-than-temporary impairments: |
||||||||
Fixed maturity securities |
0 | (1,283 | ) | |||||
Equity securities |
0 | (226 | ) | |||||
Other investments |
0 | (330 | ) | |||||
|
|
|
|
|||||
Total net realized losses related to other-than-temporary impairments |
0 | (1,839 | ) | |||||
|
|
|
|
|||||
Total net realized gains |
$ | 13,038 | $ | 7,544 | ||||
|
|
|
|
Other-Than-Temporary Impairments
The Company follows OTTI guidance which requires entities to separate an OTTI of a debt security into two components when there are credit related losses associated with the impaired debt security for which the Company asserts that it does not have the intent to sell, and it is more likely than not that it will not be required to sell before recovery of its cost basis. Under the OTTI guidance, the amount of the OTTI related to a credit loss is recognized in earnings, and the amount of the OTTI related to other, non-credit, factors (e.g., interest rates, market conditions, etc.) is recorded as a component of other comprehensive income. In instances where no credit loss exists but the Company intends to sell the security or it is more likely than not that the Company will have to sell the debt security prior to the anticipated recovery, the decline in market value below amortized cost is recognized as an OTTI in earnings. In periods after the recognition of an OTTI on debt securities, the Company accounts for such securities as if they had been purchased on the measurement date of the OTTI at an amortized cost basis equal to the previous amortized cost basis less the OTTI recognized in earnings. For debt securities for which OTTI was recognized in earnings, the difference between the new amortized cost basis and the cash flows expected to be collected will be accreted or amortized into net investment income.
There was no OTTI for the three months ended March 31, 2013. For the three months ended March 31, 2012, the Company recorded $1,936 of OTTI, of which $1,839 was related to credit losses and recorded as net OTTI losses recognized in earnings, with the remaining $97 related to all other factors and recorded as an unrealized loss component of accumulated other comprehensive income (AOCI).
The following table sets forth the amount of credit loss impairments recognized within the results of operations on fixed maturity securities held by the Company as of the dates indicated, for which a portion of the OTTI loss was recognized in AOCI, and the corresponding changes in such amounts.
11
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Balance, January 1 |
$ | 95,589 | $ | 103,090 | ||||
Additions for credit loss impairments recognized in the current period on securities previously impaired |
0 | 56 | ||||||
Reductions for increases in cash flows expected to be collected that are recognized over the remaining life of the security |
(352 | ) | (215 | ) | ||||
Reductions for credit loss impairments previously recognized on securities which matured, paid down, prepaid or were sold during the period |
(578 | ) | (578 | ) | ||||
|
|
|
|
|||||
Balance, March 31 |
$ | 94,659 | $ | 102,353 | ||||
|
|
|
|
We regularly monitor our investment portfolio to ensure investments that may be other-than-temporarily impaired are identified in a timely fashion, properly valued, and charged against earnings in the proper period. The determination that a security has incurred an other-than-temporary decline in value requires the judgment of management. Assessment factors include, but are not limited to, the length of time and the extent to which the market value has been less than cost, the financial condition and rating of the issuer, whether any collateral is held, the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery for equity securities and the intent to sell or whether it is more likely than not that the Company will be required to sell for fixed maturity securities. Inherently, there are risks and uncertainties involved in making these judgments. Changes in circumstances and critical assumptions such as a continued weak economy, a more pronounced economic downturn or unforeseen events which affect one or more companies, industry sectors, or countries could result in additional impairments in future periods for other-than-temporary declines in value. Any equity security whose price decline is deemed other-than-temporary is written down to its then current market value with the amount of the impairment reported as a realized loss in that period. The impairment of a fixed maturity security that the Company has the intent to sell or that it is more likely than not that the Company will be required to sell is deemed other-than-temporary and is written down to its market value at the balance sheet date with the amount of the impairment reported as a realized loss in that period. For all other-than-temporarily impaired fixed maturity securities that do not meet either of these two criteria, the Company is required to analyze its ability to recover the amortized cost of the security by calculating the net present value of projected future cash flows. For these other-than-temporarily impaired fixed maturity securities, the net amount recognized in earnings is equal to the difference between the amortized cost of the fixed maturity security and its net present value.
The Company considers different factors to determine the amount of projected future cash flows and discounting methods for corporate debt and residential and commercial mortgage-backed or asset-backed securities. For corporate debt securities, the split between the credit and non-credit losses is driven principally by assumptions regarding the amount and timing of projected future cash flows. The net present value is calculated by discounting the Companys best estimate of projected future cash flows at the effective interest rate implicit in the security at the date of acquisition. For residential and commercial mortgage-backed and asset-backed securities, cash flow estimates, including prepayment assumptions, are based on data from widely accepted third-party data sources or internal estimates. In addition to prepayment assumptions, cash flow estimates vary based on assumptions regarding the underlying collateral including default rates, recoveries and changes in value. The net present value is calculated by discounting the Companys best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security prior to impairment at the balance sheet date. The discounted cash flows become the new amortized cost basis of the fixed maturity security.
In periods subsequent to the recognition of an OTTI, the Company generally accretes the discount (or amortizes the reduced premium) into net investment income, up to the non-discounted amount of projected future cash flows, resulting from the reduction in cost basis, based upon the amount and timing of the expected future cash flows over the estimated period of cash flows.
12
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
The investment category and duration of the Companys gross unrealized losses on fixed maturity securities and equity securities at March 31, 2013 and December 31, 2012 were as follows:
March 31, 2013 | ||||||||||||||||||||||||
Less than 12 months | 12 Months or More | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
|||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||
United States Government and government agencies and authorities |
$ | 21,200 | $ | (170 | ) | $ | 0 | $ | 0 | $ | 21,200 | $ | (170 | ) | ||||||||||
States, municipalities and political subdivisions |
0 | 0 | 4,655 | (20 | ) | 4,655 | (20 | ) | ||||||||||||||||
Foreign governments |
74,204 | (905 | ) | 9,425 | (654 | ) | 83,629 | (1,559 | ) | |||||||||||||||
Asset-backed |
0 | 0 | 2,730 | (164 | ) | 2,730 | (164 | ) | ||||||||||||||||
Residential mortgage-backed |
93,934 | (1,032 | ) | 8,671 | (9 | ) | 102,605 | (1,041 | ) | |||||||||||||||
Corporate |
407,014 | (5,109 | ) | 37,439 | (2,138 | ) | 444,453 | (7,247 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total fixed maturity securities |
$ | 596,352 | $ | (7,216 | ) | $ | 62,920 | $ | (2,985 | ) | $ | 659,272 | $ | (10,201 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Equity securities: |
||||||||||||||||||||||||
Non-redeemable preferred stocks |
$ | 18,888 | $ | (346 | ) | $ | 31,479 | $ | (1,858 | ) | $ | 50,367 | $ | (2,204 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2012 | ||||||||||||||||||||||||
Less than 12 months | 12 Months or More | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
|||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||
United States Government and government agencies and authorities |
$ | 233,559 | $ | (127 | ) | $ | 0 | $ | 0 | $ | 233,559 | $ | (127 | ) | ||||||||||
States, municipalities and political subdivisions |
0 | 0 | 4,575 | (96 | ) | 4,575 | (96 | ) | ||||||||||||||||
Foreign governments |
41,917 | (204 | ) | 8,925 | (1,155 | ) | 50,842 | (1,359 | ) | |||||||||||||||
Asset-backed |
0 | 0 | 2,662 | (422 | ) | 2,662 | (422 | ) | ||||||||||||||||
Residential mortgage-backed |
56,674 | (509 | ) | 9,300 | (45 | ) | 65,974 | (554 | ) | |||||||||||||||
Corporate |
459,797 | (5,802 | ) | 62,778 | (3,748 | ) | 522,575 | (9,550 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total fixed maturity securities |
$ | 791,947 | $ | (6,642 | ) | $ | 88,240 | $ | (5,466 | ) | $ | 880,187 | $ | (12,108 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Equity securities: |
||||||||||||||||||||||||
Non-redeemable preferred stocks |
$ | 52,508 | $ | (416 | ) | $ | 48,626 | $ | (4,700 | ) | $ | 101,134 | $ | (5,116 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Total gross unrealized losses represent less than 2% of the aggregate fair value of the related securities at March 31, 2013 and December 31, 2012. Approximately 61% and 41% of these gross unrealized losses have been in a continuous loss position for less than twelve months at March 31, 2013 and December 31, 2012, respectively. The total gross unrealized losses are comprised of 224 and 238 individual securities at March 31, 2013 and December 31, 2012, respectively. In accordance with its policy described above, the Company concluded that for these securities an adjustment to its results of operations for other-than-temporary impairments of the gross unrealized losses was not warranted at March 31, 2013 and December 31, 2012. These conclusions are based on a detailed analysis of the underlying credit and expected cash flows of each security. As of March 31, 2013, the gross unrealized losses that have been in a continuous loss position for twelve months or more were concentrated in the Companys corporate fixed maturity securities and in non-redeemable preferred stocks. Within the Companys corporate fixed maturity securities, the majority of the loss position relates to securities in the financial industry sector. The financial industry sectors gross unrealized losses of twelve months or more
13
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
were $1,324, or 62%, of the corporate fixed maturity total. The non-redeemable preferred stocks are perpetual preferred securities that have characteristics of both debt and equity securities. To evaluate these securities, we apply an impairment model similar to that used for our fixed maturity securities. As of March 31, 2013, the Company did not intend to sell these securities and it was not more likely than not that the Company would be required to sell them and no underlying cash flow issues were noted. Therefore, the Company did not recognize an OTTI on those perpetual preferred securities that had been in a continuous unrealized loss position for twelve months or more. As of March 31, 2013, the Company did not intend to sell the fixed maturity securities and it was not more likely than not that the Company would be required to sell the securities before the anticipated recovery of their amortized cost basis. The gross unrealized losses are primarily attributable to widening credit spreads associated with an underlying shift in overall credit risk premium.
The Company has made commercial mortgage loans, collateralized by the underlying real estate, on properties located throughout the U.S. and Canada. At March 31, 2013, approximately 37% of the outstanding principal balance of commercial mortgage loans was concentrated in the states of California, New York, and Utah. Although the Company has a diversified loan portfolio, an economic downturn could have an adverse impact on the ability of its debtors to repay their loans. The outstanding balance of commercial mortgage loans range in size from $38 to $15,850 at March 31, 2013 and from $36 to $15,939 at December 31, 2012.
Credit quality indicators for commercial mortgage loans are loan-to-value and debt-service coverage ratios. Loan-to-value and debt-service coverage ratios are measures commonly used to assess the credit quality of commercial mortgage loans. The loan-to-value ratio compares the principal amount of the loan to the fair value of the underlying property collateralizing the loan, and is commonly expressed as a percentage. The debt-service coverage ratio compares a propertys net operating income to its debt-service payments and is commonly expressed as a ratio. The loan-to-value and debt-service coverage ratios are generally updated annually in the third quarter.
The following summarizes our loan-to value and average debt-service coverage ratios as of the dates indicated:
March 31, 2013 | ||||||||||||
Loan-to-Value |
Carrying Value |
% of Gross Mortgage Loans |
Debt-Service Coverage Ratio |
|||||||||
70% and less |
$ | 1,133,983 | 87.4 | % | 1.93 | |||||||
71 80% |
92,634 | 7.1 | % | 1.35 | ||||||||
81 95% |
52,608 | 4.1 | % | 1.04 | ||||||||
Greater than 95% |
17,775 | 1.4 | % | 1.05 | ||||||||
|
|
|
|
|||||||||
Gross commercial mortgage loans |
1,297,000 | 100.0 | % | 1.84 | ||||||||
|
|
|||||||||||
Less valuation allowance |
(6,997 | ) | ||||||||||
|
|
|||||||||||
Net commercial mortgage loans |
$ | 1,290,003 | ||||||||||
|
|
December 31, 2012 | ||||||||||||
Loan-to-Value |
Carrying Value |
% of Gross Mortgage Loans |
Debt-Service Coverage Ratio |
|||||||||
70% and less |
$ | 1,141,564 | 86.6 | % | 1.95 | |||||||
71 80% |
103,152 | 7.8 | % | 1.30 | ||||||||
81 95% |
57,413 | 4.3 | % | 1.04 | ||||||||
Greater than 95% |
16,550 | 1.3 | % | 1.02 | ||||||||
|
|
|
|
|||||||||
Gross commercial mortgage loans |
1,318,679 | 100.0 | % | 1.85 | ||||||||
|
|
|||||||||||
Less valuation allowance |
(6,997 | ) | ||||||||||
|
|
|||||||||||
Net commercial mortgage loans |
$ | 1,311,682 | ||||||||||
|
|
All commercial mortgage loans that are individually impaired have an established mortgage loan valuation allowance for losses. Changing economic conditions affect our valuation of commercial mortgage loans. Changing vacancies and rents are incorporated into the discounted cash flow analysis that we perform for monitored loans and may contribute to the establishment of (or an increase
14
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
or decrease in) a commercial mortgage loan valuation allowance for losses. In addition, we continue to monitor the entire commercial mortgage loan portfolio to identify risk. Areas of emphasis are properties that have exposure to earthquakes, have deteriorating credits or have experienced a reduction in debt-service coverage ratio. Where warranted, we have established or increased a valuation allowance based upon this analysis.
Collateralized Transactions
The Company engages in transactions in which fixed maturity securities, primarily bonds issued by the U.S. government and government agencies and authorities, and U.S. corporations, are loaned to selected broker/dealers. Collateral, greater than or equal to 102% of the fair value of the securities lent, plus accrued interest, is received in the form of cash and cash equivalents held by a custodian bank for the benefit of the Company. The use of cash collateral received is unrestricted. The Company reinvests the cash collateral received, generally in investments of high credit quality that are designated as available-for-sale. The Company monitors the fair value of securities loaned and the collateral received, with additional collateral obtained, as necessary. The Company is subject to the risk of loss to the extent there is a loss on the re-investment of cash collateral.
As of March 31, 2013 and December 31, 2012, our collateral held under securities lending, of which its use is unrestricted, was $94,629 and $94,729, respectively, and is included in the consolidated balance sheets under the collateral held/pledged under securities agreements. Our liability to the borrower for collateral received was $94,611 and $94,714, respectively, and is included in the consolidated balance sheets under the obligation under securities agreements. The difference between the collateral held and obligations under securities lending is recorded as an unrealized gain and is included as part of AOCI. The Company includes the available-for-sale investments purchased with the cash collateral in its evaluation of other-than-temporary impairments.
Cash proceeds that the Company receives as collateral for the securities it lends and subsequent repayment of the cash are regarded by the Company as cash flows from financing activities, since the cash received is considered a borrowing. Since the Company reinvests the cash collateral generally in investments that are designated as available-for-sale, the reinvestment is presented as cash flows from investing activities.
5. Fair Value Disclosures
Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures
The fair value measurements and disclosures guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.
The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Companys assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.
The levels of the fair value hierarchy are described below:
| Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access. |
| Level 2 inputs utilize other than quoted prices included in Level 1 that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Level 2 inputs include quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active and inputs other than quoted prices that are observable in the marketplace for the asset. The observable inputs are used in valuation models to calculate the fair value for the asset. |
15
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
| Level 3 inputs are unobservable but are significant to the fair value measurement for the asset, and include situations where there is little, if any, market activity for the asset. These inputs reflect managements own assumptions about the assumptions a market participant would use in pricing the asset. |
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy.
The following tables present the Companys fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012. The amounts presented below for Collateral held/pledged under securities agreements, Other investments, Cash equivalents, Other assets, Assets and Liabilities held in separate accounts and Other liabilities differ from the amounts presented in the consolidated balance sheets because only certain investments or certain assets and liabilities within these line items are measured at estimated fair value. Other investments are comprised of investments in the Assurant Investment Plan, American Security Insurance Company Investment Plan, Assurant Deferred Compensation Plan, a modified coinsurance arrangement and other derivatives. Other liabilities are comprised of investments in the Assurant Investment Plan and other derivatives. The fair value amount and the majority of the associated levels presented for Other investments and Assets held in separate accounts are received directly from third parties.
16
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
March 31, 2013 | ||||||||||||||||
Financial Assets |
Total | Level 1 | Level 2 | Level 3 | ||||||||||||
Fixed maturity securities: |
||||||||||||||||
United States Government and government agencies and authorities |
$ | 528,085 | $ | 0 | $ | 524,019 | $ | 4,066 | ||||||||
State, municipalities and political subdivisions |
895,887 | 0 | 895,887 | 0 | ||||||||||||
Foreign governments |
719,332 | 710 | 696,080 | 22,542 | ||||||||||||
Asset-backed |
14,617 | 0 | 14,617 | 0 | ||||||||||||
Commercial mortgage-backed |
65,760 | 0 | 64,958 | 802 | ||||||||||||
Residential mortgage-backed |
788,094 | 0 | 762,754 | 25,340 | ||||||||||||
Corporate |
9,132,025 | 0 | 8,989,855 | 142,170 | ||||||||||||
Equity securities: |
||||||||||||||||
Common stocks |
21,444 | 20,761 | 683 | 0 | ||||||||||||
Non-redeemable preferred stocks |
454,321 | 0 | 452,285 | 2,036 | ||||||||||||
Short-term investments |
239,782 | 152,956 | b | 86,826 | c | 0 | ||||||||||
Collateral held/pledged under securities agreements |
74,629 | 68,008 | b | 6,621 | c | 0 | ||||||||||
Other investments |
253,651 | 54,447 | a | 188,170 | c | 11,034 | d | |||||||||
Cash equivalents |
1,058,043 | 1,049,163 | b | 8,880 | c | 0 | ||||||||||
Other assets |
5,816 | 0 | 1,145 | f | 4,671 | e | ||||||||||
Assets held in separate accounts |
1,750,516 | 1,547,615 | a | 202,901 | c | 0 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial assets |
$ | 16,002,002 | $ | 2,893,660 | $ | 12,895,681 | $ | 212,661 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities |
||||||||||||||||
Other liabilities |
$ | 56,553 | $ | 54,447 | a | $ | 181 | f | $ | 1,925 | f | |||||
Liabilities related to separate accounts |
1,750,516 | 1,547,615 | a | 202,901 | c | 0 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities |
$ | 1,807,069 | $ | 1,602,062 | $ | 203,082 | $ | 1,925 | ||||||||
|
|
|
|
|
|
|
|
17
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
December 31, 2012 | ||||||||||||||||
Financial Assets |
Total | Level 1 | Level 2 | Level 3 | ||||||||||||
Fixed maturity securities: |
||||||||||||||||
United States Government and government agencies and authorities |
$ | 641,924 | $ | 0 | $ | 637,749 | $ | 4,175 | ||||||||
State, municipalities and political subdivisions |
907,056 | 0 | 907,056 | 0 | ||||||||||||
Foreign governments |
753,408 | 672 | 729,639 | 23,097 | ||||||||||||
Asset-backed |
28,197 | 0 | 28,197 | 0 | ||||||||||||
Commercial mortgage-backed |
69,883 | 0 | 68,109 | 1,774 | ||||||||||||
Residential mortgage-backed |
771,057 | 0 | 762,846 | 8,211 | ||||||||||||
Corporate |
9,000,113 | 0 | 8,842,110 | 158,003 | ||||||||||||
Equity securities: |
||||||||||||||||
Common stocks |
18,950 | 18,267 | 683 | 0 | ||||||||||||
Non-redeemable preferred stocks |
456,856 | 0 | 456,842 | 14 | ||||||||||||
Short-term investments |
300,925 | 201,803 | b | 99,122 | c | 0 | ||||||||||
Collateral held/pledged under securities agreements |
74,729 | 68,939 | b | 5,790 | c | 0 | ||||||||||
Other investments |
250,806 | 49,199 | a | 190,280 | c | 11,327 | d | |||||||||
Cash equivalents |
381,777 | 366,543 | b | 15,234 | c | 0 | ||||||||||
Other assets |
6,609 | 0 | 723 | f | 5,886 | e | ||||||||||
Assets held in separate accounts |
1,674,406 | 1,469,050 | a | 205,356 | c | 0 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial assets |
$ | 15,336,696 | $ | 2,174,473 | $ | 12,949,736 | $ | 212,487 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities |
||||||||||||||||
Other liabilities |
$ | 51,828 | $ | 49,199 | a | $ | 69 | f | $ | 2,560 | f | |||||
Liabilities related to separate accounts |
1,674,406 | 1,469,050 | a | 205,356 | c | 0 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities |
$ | 1,726,234 | $ | 1,518,249 | $ | 205,425 | $ | 2,560 | ||||||||
|
|
|
|
|
|
|
|
a. | Mainly includes mutual funds. |
b. | Mainly includes money market funds. |
c. | Mainly includes fixed maturity securities. |
d. | Mainly includes fixed maturity securities and other derivatives |
e. | Mainly includes the Consumer Price Index Cap Derivatives (CPI Caps). |
f. | Mainly includes other derivatives. |
18
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
There were no transfers between Level 1 and Level 2 financial assets during the period. However, there were transfers between Level 2 and Level 3 financial assets during the period, which are reflected in the Transfers in and Transfers out columns below. Transfers between Level 2 and Level 3 most commonly occur when market observable inputs that were previously available become unavailable in the current period. The remaining unpriced securities are submitted to independent brokers who provide non-binding broker quotes or are priced by other qualified sources.
The following tables summarize the change in balance sheet carrying value associated with Level 3 financial assets and liabilities carried at fair value during the three months ended March 31, 2013 and 2012:
Three Months Ended March 31, 2013 | ||||||||||||||||||||||||||||||||
Balance, beginning of period |
Total (losses) gains (realized/ unrealized) included in earnings (1) |
Net unrealized (losses) gains included in other comprehensive income (2) |
Purchases | Sales | Transfers in (3) |
Transfers out (3) |
Balance, end of period |
|||||||||||||||||||||||||
Fixed Maturity Securities |
||||||||||||||||||||||||||||||||
United States Government and government agencies and authorities |
$ | 4,175 | $ | 0 | $ | (1 | ) | $ | 0 | $ | (108 | ) | $ | 0 | $ | 0 | $ | 4,066 | ||||||||||||||
Foreign governments |
23,097 | (1 | ) | (554 | ) | 0 | 0 | 0 | 0 | 22,542 | ||||||||||||||||||||||
Commercial mortgage-backed |
1,774 | 19 | (19 | ) | 0 | (972 | ) | 0 | 0 | 802 | ||||||||||||||||||||||
Residential mortgage-backed |
8,211 | (10 | ) | (120 | ) | 17,750 | (491 | ) | 0 | 0 | 25,340 | |||||||||||||||||||||
Corporate |
158,003 | (39 | ) | 444 | 0 | (7,467 | ) | 0 | (8,771 | ) | 142,170 | |||||||||||||||||||||
Equity Securities |
||||||||||||||||||||||||||||||||
Non-redeemable preferred stocks |
14 | 0 | 7 | 2,028 | 0 | 0 | (13 | ) | 2,036 | |||||||||||||||||||||||
Other investments |
11,327 | (591 | ) | 332 | 8 | (42 | ) | 0 | 0 | 11,034 | ||||||||||||||||||||||
Other assets |
5,886 | (1,215 | ) | 0 | 0 | 0 | 0 | 0 | 4,671 | |||||||||||||||||||||||
Financial Liabilities |
||||||||||||||||||||||||||||||||
Other liabilities |
(2,560 | ) | 635 | 0 | 0 | 0 | 0 | 0 | (1,925 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total level 3 assets and liabilities |
$ | 209,927 | $ | (1,202 | ) | $ | 89 | $ | 19,786 | $ | (9,080 | ) | $ | 0 | $ | (8,784 | ) | $ | 210,736 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Three Months Ended March 31, 2012 | ||||||||||||||||||||||||||||||||
Balance, beginning of period |
Total (losses) gains (realized/ unrealized) included in earnings (1) |
Net unrealized (losses) gains included in other comprehensive income (2) |
Purchases | Sales | Transfers in (3) |
Transfers out (3) |
Balance, end of period |
|||||||||||||||||||||||||
Fixed Maturity Securities |
||||||||||||||||||||||||||||||||
United States Government and government agencies and authorities |
$ | 4,400 | $ | (1 | ) | $ | (2 | ) | $ | 0 | $ | (104 | ) | $ | 0 | $ | 0 | $ | 4,293 | |||||||||||||
Foreign governments |
22,713 | (1 | ) | 732 | 0 | 0 | 0 | 0 | 23,444 | |||||||||||||||||||||||
Asset-backed |
453 | 0 | 0 | 0 | 0 | 0 | (453 | ) | 0 | |||||||||||||||||||||||
Commercial mortgage- backed |
904 | 0 | (2 | ) | 0 | (38 | ) | 0 | 0 | 864 | ||||||||||||||||||||||
Residential mortgage- backed |
1,867 | 3 | 25 | 1,930 | (115 | ) | 0 | (1,866 | ) | 1,844 | ||||||||||||||||||||||
Corporate |
137,629 | (99 | ) | 3,829 | 2,155 | (7,767 | ) | 8,986 | (1,453 | ) | 143,280 | |||||||||||||||||||||
Equity Securities |
||||||||||||||||||||||||||||||||
Non-redeemable preferred stocks |
13 | 0 | 2 | 0 | 0 | 1 | 0 | 16 | ||||||||||||||||||||||||
Other investments |
18,257 | (449 | ) | 418 | 0 | (8,090 | ) | 1,488 | 0 | 11,624 | ||||||||||||||||||||||
Other assets |
8,521 | (1,769 | ) | 0 | 0 | 0 | 0 | 0 | 6,752 | |||||||||||||||||||||||
Financial Liabilities |
||||||||||||||||||||||||||||||||
Other liabilities |
(2,720 | ) | 562 | 0 | 0 | 0 | 0 | 0 | (2,158 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total level 3 assets and liabilities |
$ | 192,037 | $ | (1,754 | ) | $ | 5,002 | $ | 4,085 | $ | (16,114 | ) | $ | 10,475 | $ | (3,772 | ) | $ | 189,959 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Included as part of net realized gains on investments in the consolidated statement of operations. |
(2) | Included as part of change in unrealized gains on securities in the consolidated statement of comprehensive income. |
(3) | Transfers are primarily attributable to changes in the availability of observable market information and re-evaluation of the observability of pricing inputs. |
Three different valuation techniques can be used in determining fair value for financial assets and liabilities: the market, income or cost approaches. The three valuation techniques described in the fair value measurements and disclosures guidance are consistent with generally accepted valuation methodologies. The market approach valuation techniques use prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. When possible, quoted prices (unadjusted) in active markets are used as of the period-end date (such as for mutual funds and money market funds). Otherwise, valuation techniques consistent with the market approach including matrix pricing and comparables are used. Matrix pricing is a mathematical technique
20
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
employed principally to value debt securities without relying exclusively on quoted prices for those securities but rather by relying on the securities relationship to other benchmark quoted securities. Market approach valuation techniques often use market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range the appropriate multiple falls requires judgment, considering both qualitative and quantitative factors specific to the measurement.
Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present amount, or a discounted amount. These techniques rely on current market expectations of future amounts as of the period-end date. Examples of income approach valuation techniques include present value techniques, option-pricing models, binomial or lattice models that incorporate present value techniques and the multi-period excess earnings method.
Cost approach valuation techniques are based upon the amount that would be required to replace the service capacity of an asset at the period-end date, or the current replacement cost. That is, from the perspective of a market participant (seller), the price that would be received for the asset is determined based on the cost to a market participant (buyer) to acquire or construct a substitute asset of comparable utility, adjusted for obsolescence.
While not all three approaches are applicable to all financial assets or liabilities, where appropriate, one or more valuation techniques may be used. For all the classes of financial assets and liabilities included in the above hierarchy, excluding the CPI Caps and certain privately placed corporate bonds, the market valuation technique is generally used. For certain privately placed corporate bonds and the CPI Caps, the income valuation technique is generally used. For the periods ended March 31, 2013 and December 31, 2012, the application of the valuation technique applied to the Companys classes of financial assets and liabilities has been consistent.
Level 1 Securities
The Companys investments and liabilities classified as Level 1 as of March 31, 2013 and December 31, 2012, consisted of mutual funds and money market funds, foreign government fixed maturities and common stocks that are publicly listed and/or actively traded in an established market.
Level 2 Securities
The Companys Level 2 securities are valued using various observable market inputs obtained from a pricing service. The pricing service prepares estimates of fair value measurements for our Level 2 securities using proprietary valuation models based on techniques such as matrix pricing which include observable market inputs. The fair value measurements and disclosures guidance defines observable market inputs as the assumptions market participants would use in pricing the asset or liability developed on market data obtained from sources independent of the Company. The extent of the use of each observable market input for a security depends on the type of security and the market conditions at the balance sheet date. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary. The following observable market inputs (standard inputs), listed in the approximate order of priority, are utilized in the pricing evaluation of Level 2 securities: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research data. Further details for Level 2 investment types follow:
United States Government and government agencies and authorities: United States government and government agencies and authorities securities are priced by our pricing vendor utilizing standard inputs. Included in this category are U.S. Treasury securities which are priced using vendor trading platform data in addition to the standard inputs.
State, municipalities and political subdivisions: State, municipalities and political subdivisions securities are priced by our pricing service utilizing material event notices and new issue data inputs in addition to the standard inputs.
Foreign governments: Foreign government securities are primarily fixed maturity securities denominated in Canadian dollars which are priced by our pricing service utilizing standard inputs. The pricing service also evaluates each security based on relevant market information including relevant credit information, perceived market movements and sector news.
Commercial mortgage-backed, residential mortgage-backed and asset-backed: Commercial mortgage-backed, residential mortgage-backed and asset-backed securities are priced by our pricing vendor utilizing monthly payment information and collateral performance information in addition to standard inputs. Additionally, commercial mortgage-backed securities and asset-backed securities utilize new issue data while residential mortgage-backed securities utilize vendor trading platform data.
21
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Corporate: Corporate securities are priced by our pricing vendor utilizing standard inputs. Non-investment grade securities within this category are priced by our pricing vendor utilizing observations of equity and credit default swap curves related to the issuer in addition to standard inputs. Certain privately placed corporate bonds are priced by a non-pricing service source using a model with observable inputs including, but not limited to, the credit rating, credit spreads, sector add-ons, and issuer specific add-ons.
Non-redeemable preferred stocks: Non-redeemable preferred stocks are priced by our pricing vendor utilizing observations of equity and credit default swap curves related to the issuer in addition to standard inputs.
Short-term investments, collateral held/pledged under securities, other investments, cash equivalents, and assets/liabilities held in separate accounts: To price the fixed maturity securities in these categories, the pricing service utilizes the standard inputs.
Valuation models used by the pricing service can change period to period, depending on the appropriate observable inputs that are available at the balance sheet date to price a security. When market observable inputs are unavailable to the pricing service, the remaining unpriced securities are submitted to independent brokers who provide non-binding broker quotes or are priced by other qualified sources. If the Company cannot corroborate the non-binding broker quotes with Level 2 inputs, these securities are categorized as Level 3 securities.
Level 3 Securities
The Companys investments classified as Level 3 as of March 31, 2013 and December 31, 2012, consisted of fixed maturity securities and derivatives. All of the Level 3 fixed maturity and equity securities are priced using non-binding broker quotes which cannot be corroborated with Level 2 inputs. Of our total Level 3 fixed maturity and equity securities, $96,904 and $102,586 were priced by a pricing service using single broker quotes due to insufficient information to provide an evaluated price as of March 31, 2013 and December 31, 2012, respectively. The single broker quotes are provided by market makers or broker-dealers who are recognized as market participants in the markets in which they are providing the quotes. The remaining $107,874 and $100,220 were priced internally using independent and non-binding broker quotes as of March 31, 2013 and December 31, 2012, respectively. The inputs factoring into the broker quotes include trades in the actual bond being priced, trades of comparable bonds, quality of the issuer, optionality, structure and liquidity. Significant changes in interest rates, issuer credit, liquidity, and overall market conditions would result in a significantly lower or higher broker quote. The prices received from both the pricing service and internally are reviewed for reasonableness by management and if necessary, management works with the pricing service or broker to further understand how they developed their price. Further details on Level 3 derivative investment types follow:
Other investments and other liabilities: Swaptions are priced using a Black-Scholes pricing model incorporating third-party market data, including swap volatility data.
Other assets: A non-pricing service source prices the CPI Cap derivatives using a model with inputs including, but not limited to, the time to expiration, the notional amount, the strike price, the forward rate, implied volatility and the discount rate.
Management evaluates the following factors in order to determine whether the market for a financial asset is inactive. The factors include, but are not limited to:
| There are few recent transactions, |
| Little information is released publicly, |
| The available prices vary significantly over time or among market participants, |
| The prices are stale (i.e., not current), and |
| The magnitude of the bid-ask spread. |
22
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Illiquidity did not have a material impact in the fair value determination of the Companys financial assets.
The Company generally obtains one price for each financial asset. The Company performs a monthly analysis to assess if the evaluated prices represent a reasonable estimate of their fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include, but are not limited to, initial and on-going review of pricing service methodologies, review of the prices received from the pricing service, review of pricing statistics and trends, and comparison of prices for certain securities with two different appropriate price sources for reasonableness. Following this analysis, the Company generally uses the best estimate of fair value based upon all available inputs. On infrequent occasions, a non-pricing service source may be more familiar with the market activity for a particular security than the pricing service. In these cases the price used is taken from the non-pricing service source. The pricing service provides information to indicate which securities were priced using market observable inputs so that the Company can properly categorize our financial assets in the fair value hierarchy.
Disclosures for Non-Financial Assets Measured at Fair Value on a Non-Recurring Basis
The Company also measures the fair value of certain assets on a non-recurring basis, generally on an annual basis, or when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. These assets include commercial mortgage loans, goodwill and finite-lived intangible assets.
The Company utilizes both the income and market valuation approaches to measure the fair value of its reporting units when required. Under the income approach, the Company determined the fair value of the reporting units considering distributable earnings, which were estimated from operating plans. The resulting cash flows were then discounted using a market participant weighted average cost of capital estimated for the reporting units. After discounting the future discrete earnings to their present value, the Company estimated the terminal value attributable to the years beyond the discrete operating plan period. The discounted terminal value was then added to the aggregate discounted distributable earnings from the discrete operating plan period to estimate the fair value of the reporting units. Under the market approach, the Company derived the fair value of the reporting units based on various financial multiples, including but not limited to: price to tangible book value of equity, price to estimated 2013 earnings and price to estimated 2014 earnings, which were estimated based on publicly available data related to comparable guideline companies. In addition, financial multiples were also estimated from publicly available purchase price data for acquisitions of companies operating in the insurance industry. The estimated fair value of the reporting units was more heavily weighted towards the income approach because in the current economic environment the earnings capacity of a business is generally considered the most important factor in the valuation of a business enterprise. This fair value determination was categorized as Level 3 (unobservable) in the fair value hierarchy.
Fair Value of Financial Instruments Disclosures
The financial instruments guidance requires disclosure of fair value information about financial instruments, as defined therein, for which it is practicable to estimate such fair value. Therefore, it requires fair value disclosure for financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets. However, this guidance excludes certain financial instruments, including those related to insurance contracts and those accounted for under the equity method and joint ventures guidance (such as real estate joint ventures).
For the financial instruments included within the following financial assets and financial liabilities, the carrying value in the consolidated balance sheets equals or approximates fair value. Please refer to the Fair Value Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures section above for more information on the financial instruments included within the following financial assets and financial liabilities and the methods and assumptions used to estimate fair value:
| Cash and cash equivalents |
| Fixed maturity securities |
| Equity securities |
| Short-term investments |
| Collateral held/pledged under securities agreements |
23
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
| Other investments |
| Other assets |
| Assets held in separate accounts |
| Other liabilities |
| Liabilities related to separate accounts |
In estimating the fair value of the financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets, the Company used the following methods and assumptions:
Commercial mortgage loans: the fair values of mortgage loans are estimated using discounted cash flow models. The model inputs include mortgage amortization schedules and loan provisions, an internally developed credit spread based on the credit risk associated with the borrower and the U.S. Treasury spot curve. Mortgage loans with similar characteristics are aggregated for purposes of the calculations.
Policy loans: the carrying value of policy loans reported in the balance sheets approximates fair value.
Policy reserves under investment product: the fair values for the Companys policy reserves under investment products are determined using discounted cash flow analysis. Key inputs to the valuation include projections of policy cash flows, reserve run-off, market yields and risk margins.
Funds held under reinsurance: the carrying value reported approximates fair value due to the short maturity of the instruments.
Debt: the fair value of debt is based upon matrix pricing performed by the pricing service utilizing the standard inputs.
Obligations under securities agreements: obligation under securities agreements is reported at the amount of cash received from the selected broker/dealers.
The following table discloses the carrying value, fair value amount and hierarchy level of the financial instruments that are not recognized or are not carried at fair value in the consolidated balance sheets:
24
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
March 31, 2013 | ||||||||||||||||||||
Fair Value | ||||||||||||||||||||
Financial Assets |
Carrying Value |
Total | Level 1 | Level 2 | Level 3 | |||||||||||||||
Commercial mortgage loans on real estate |
$ | 1,290,003 | $ | 1,456,670 | $ | 0 | $ | 0 | $ | 1,456,670 | ||||||||||
Policy loans |
52,939 | 52,939 | 52,939 | 0 | 0 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total financial assets |
$ | 1,342,942 | $ | 1,509,609 | $ | 52,939 | $ | 0 | $ | 1,456,670 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Financial Liabilities |
||||||||||||||||||||
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal) |
$ | 846,330 | $ | 889,274 | $ | 0 | $ | 0 | $ | 889,274 | ||||||||||
Funds withheld under reinsurance |
60,905 | 60,905 | 60,905 | 0 | 0 | |||||||||||||||
Debt |
1,670,523 | 1,736,974 | 0 | 1,736,974 | 0 | |||||||||||||||
Obligation under securities agreements |
94,611 | 94,611 | 94,611 | 0 | 0 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total financial liabilities |
$ | 2,672,369 | $ | 2,781,764 | $ | 155,516 | $ | 1,736,974 | $ | 889,274 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
December 31, 2012 | ||||||||||||||||||||
Fair Value | ||||||||||||||||||||
Financial Assets | Carrying Value |
Total | Level 1 | Level 2 | Level 3 | |||||||||||||||
Commercial mortgage loans on real estate |
$ | 1,311,682 | $ | 1,468,723 | $ | 0 | $ | 0 | $ | 1,468,723 | ||||||||||
Policy loans |
52,938 | 52,938 | 52,938 | 0 | 0 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total financial assets |
$ | 1,364,620 | $ | 1,521,661 | $ | 52,938 | $ | 0 | $ | 1,468,723 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Financial Liabilities |
||||||||||||||||||||
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal) |
$ | 862,398 | $ | 902,449 | $ | 0 | $ | 0 | $ | 902,449 | ||||||||||
Funds withheld under reinsurance |
61,413 | 61,413 | 61,413 | 0 | 0 | |||||||||||||||
Debt |
972,399 | 1,050,920 | 0 | 1,050,920 | 0 | |||||||||||||||
Obligation under securities agreements |
94,714 | 94,714 | 94,714 | 0 | 0 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total financial liabilities |
$ | 1,990,924 | $ | 2,109,496 | $ | 156,127 | $ | 1,050,920 | $ | 902,449 | ||||||||||
|
|
|
|
|
|
|
|
|
|
25
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Only the fair value of the Companys policy reserves for investment-type contracts, (those without significant mortality or morbidity risk) are reflected in the table above.
Reinsurance Recoverables Credit Disclosures
A key credit quality indicator for reinsurance is the A.M. Best financial strength ratings of the reinsurer. The A.M. Best ratings are an independent opinion of a reinsurers ability to meet ongoing obligations to policyholders. The A.M. Best ratings for new reinsurance agreements where there is material credit exposure are reviewed at the time of execution. The A.M. Best ratings for existing reinsurance agreements are reviewed on a periodic basis, at least annually. The A.M. Best ratings have not changed significantly since December 31, 2012.
An allowance for doubtful accounts for reinsurance recoverables is recorded on the basis of periodic evaluations of balances due from reinsurers (net of collateral), reinsurer solvency, managements experience and current economic conditions. Information about the allowance for doubtful accounts for reinsurance recoverable as of March 31, 2013 is as follows:
Balance as of beginning-of-year |
$ | 10,633 | ||
Provision |
0 | |||
Other additions |
0 | |||
Direct write-downs charged against the allowance |
0 | |||
|
|
|||
Balance as of the end-of-period |
$ | 10,633 | ||
|
|
6. Debt
On March 28, 2013, the Company completed an issuance of two series of senior notes with an aggregate principal amount of $700,000 (the 2013 Senior Notes). The Company received proceeds of $698,093 from this transaction, which represents the principal amount less the discount before offering expenses. The discount of $1,907 is being amortized over the life of the 2013 Senior Notes and is included as part of interest expense on the statements of operations. The first series is $350,000 in principal amount, bears interest at 2.50% per year and is payable in a single installment due March 15, 2018 and was issued at a 0.18% discount. The second series is $350,000 in principal amount, bears interest at 4.00% per year and is payable in a single installment due March 15, 2023 and was issued at a 0.37% discount.
In February 2004, the Company issued two series of senior notes with an aggregate principal amount of $975,000 (the 2004 Senior Notes). The Company received proceeds of $971,537 from this transaction, which represents the principal amount less the discount before offering expenses. The discount of $3,463 is being amortized over the life of the 2004 Senior Notes and is included as part of interest expense on the statements of operations. The first series is $500,000 in principal amount, bears interest at 5.63% per year and is payable in a single installment due February 15, 2014 and was issued at a 0.11% discount. The second series is $475,000 in principal amount, bears interest at 6.75% per year and is payable in a single installment due February 15, 2034 and was issued at a 0.61% discount.
The interest expense incurred related to the 2004 Senior Notes was $15,078 and $15,076 for the three months ended March 31, 2013 and 2012, respectively. There was $7,523 of accrued interest at March 31, 2013 and 2012, respectively. The Company made interest payments of $30,094 on February 15, 2013 and 2012.
Credit Facility
The Companys commercial paper program requires the Company to maintain liquidity facilities either in an available amount equal to any outstanding notes from the commercial paper program or in an amount sufficient to maintain the ratings assigned to the notes issued from the commercial paper program. The Companys subsidiaries do not maintain commercial paper or other borrowing facilities at their level. This program is currently backed up by a $350,000 senior revolving credit facility, of which $328,958 was available at March 31, 2013, due to outstanding letters of credit.
26
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
On September 21, 2011, the Company entered into a four-year unsecured $350,000 revolving credit agreement (2011 Credit Facility) with a syndicate of banks arranged by JP Morgan Chase Bank, N.A. and Bank of America, N.A. The 2011 Credit Facility provides for revolving loans and the issuance of multi-bank, syndicated letters of credit and/or letters of credit from a sole issuing bank in an aggregate amount of $350,000 and is available until September 2015, provided the Company is in compliance with all covenants. The 2011 Credit Facility has a sublimit for letters of credit issued thereunder of $50,000. The proceeds of these loans may be used for the Companys commercial paper program or for general corporate purposes. The Company may increase the total amount available under the 2011 Credit Facility to $525,000 subject to certain conditions. No bank is obligated to provide commitments above their share of the $350,000 facility.
The Company did not use the commercial paper program during the three months ended March 31, 2013 and 2012 and there were no amounts outstanding relating to the commercial paper program at March 31, 2013 and December 31, 2012. The Company made no borrowings using the 2011 Credit Facility and no loans are outstanding at March 31, 2013. The Company had $21,042 of letters of credit outstanding under the 2011 Credit Facility as of March 31, 2013.
The 2011 Credit Facility contains restrictive covenants and requires that the Company maintain certain specified minimum ratios and thresholds. Among others, these covenants include maintaining a maximum debt to capitalization ratio and a minimum consolidated adjusted net worth. At March 31, 2013, the Company was in compliance with all covenants, minimum ratios and thresholds.
7. Accumulated Other Comprehensive Income
Certain amounts included in the consolidated statements of comprehensive income are net of reclassification adjustments. The following table summarizes those reclassification adjustments (net of taxes):
Foreign currency translation adjustment |
Unrealized gains on securities |
OTTI | Pension under- funding |
Accumulated other comprehensive income |
||||||||||||||||
Balance at December 31, 2012 |
$ | 6,882 | $ | 981,879 | $ | 23,861 | $ | (182,219 | ) | $ | 830,403 | |||||||||
Other comprehensive loss before reclassifications |
(10,317 | ) | (57,722 | ) | 2,605 | 6 | (65,428 | ) | ||||||||||||
Amounts reclassified from accumulated other comprehensive income |
0 | 7,610 | 0 | 5,444 | 13,054 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net current-period other comprehensive loss |
(10,317 | ) | (50,112 | ) | 2,605 | 5,450 | (52,374 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at March 31, 2013 |
$ | (3,435 | ) | $ | 931,767 | $ | 26,466 | $ | (176,769 | ) | $ | 778,029 | ||||||||
|
|
|
|
|
|
|
|
|
|
27
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
The following table summarizes the reclassifications out of accumulated other comprehensive income for the three month period ending March 31, 2013:
Details about accumulated other comprehensive income components |
Amount reclassified from
accumulated other comprehensive income |
Affected line item in the statement where net income is presented | ||||
Unrealized gains on securities |
$ | 11,707 | Net realized gains on investments, excluding other-than-temporary impairment losses | |||
(4,097) | Provision for income taxes | |||||
|
|
|||||
$ | 7,610 | Net of tax | ||||
|
|
|||||
Amortization of pension and postretirement unrecognized net periodic benefit cost: |
||||||
Amortization of prior service cost |
$ | (50) | (1) | |||
Amortization of net loss |
8,425 | (1) | ||||
|
|
|||||
8,375 | Total before tax | |||||
(2,931) | Provision for income taxes | |||||
|
|
|||||
$ | 5,444 | Net of tax | ||||
|
|
|||||
Total reclassifications for the period |
$ | 13,054 | Net of tax | |||
|
|
(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost. See Note 11Retirement and Other Employee Benefits for additional information.
8. Stock Based Compensation
Long-Term Equity Incentive Plan
In May 2008, the Companys shareholders approved the Assurant, Inc. Long-Term Equity Incentive Plan (ALTEIP), which authorized the granting of up to 3,400,000 new shares of the Companys common stock to employees, officers and non-employee directors. In May 2010, the Companys shareholders approved an amended and restated ALTEIP, increasing the number of shares of the Companys common stock authorized for issuance to 5,300,000 new shares. Under the ALTEIP, the Company may grant awards based on shares of its common stock, including stock options, stock appreciation rights (SARs), restricted stock (including performance shares), unrestricted stock, restricted stock units (RSUs), performance share units (PSUs) and dividend equivalents. All future share-based grants will be awarded under the ALTEIP.
The Compensation Committee of the Board of Directors (the Compensation Committee) awards PSUs and RSUs annually. RSUs and PSUs are promises to issue actual shares of common stock at the end of a vesting period or performance period. The RSUs granted to employees under the ALTEIP were based on salary grade and performance and vest one-third each year over a three-year period. RSUs granted to non-employee directors also vest one-third each year over a three-year period. RSUs receive dividend equivalents in cash during the restricted period and do not have voting rights during the restricted period. PSUs accrue dividend equivalents during the performance period based on a target payout, and will be paid in cash at the end of the performance period based on the actual number of shares issued. The fair value of RSUs is estimated using the fair market value of a share of the Companys common stock at the date of grant. The fair value of PSUs is estimated using the Monte Carlo simulation model and is described in further detail below.
For the PSU portion of an award, the number of shares a participant will receive upon vesting is contingent upon the Companys performance with respect to selected metrics, identified below, compared against a broad index of insurance companies and assigned a percentile ranking. These rankings are then averaged to determine the composite percentile ranking for the performance period. The payout levels can vary between 0% and 150% (maximum) of the target (100%) ALTEIP award amount based on the Companys level of performance against the selected metrics.
PSU Performance Goals. The Compensation Committee established book value per share (BVPS) growth excluding AOCI, revenue growth and total stockholder return as the three performance measures for PSU awards. BVPS growth is defined as the year-
28
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
over-year growth of the Companys stockholders equity excluding AOCI divided by the number of fully diluted total shares outstanding at the end of the period. Revenue growth is defined as the year-over-year change in total revenues as disclosed in the Companys annual statement of operations. Total stockholder return is defined as appreciation in Company stock plus dividend yield to stockholders. Payouts will be determined by measuring performance against the average performance of companies included in the A.M. Best Insurance Index, excluding those with revenues of less than $1,000,000 or that are not in the health or insurance Global Industry Classification Standard codes.
Under the ALTEIP, the Companys Chief Executive Officer (CEO) is authorized by the Board of Directors to grant common stock, restricted stock and RSUs to employees other than the executive officers of the Company (as defined in Section 16 of the Securities Exchange Act of 1934, as amended (the Exchange Act)). The Board of Directors reviews and ratifies these grants quarterly. Restricted stock and RSUs granted under this program may have different vesting periods.
Restricted Stock Units
RSUs granted to employees and to non-employee directors were 431,908 and 457,281 for the three months ended March 31, 2013 and 2012, respectively. The compensation expense recorded related to RSUs was $5,552 and $5,082 for the three months ended March 31, 2013 and 2012, respectively. The related total income tax benefit was $1,932 and $1,781 for the three months ended March 31, 2013 and 2012, respectively. The weighted average grant date fair value for RSUs granted during the three months ended March 31, 2013 and 2012 was $43.74 and $41.68, respectively.
As of March 31, 2013, there was $31,476 of unrecognized compensation cost related to outstanding RSUs. That cost is expected to be recognized over a weighted-average period of 1.59 years. The total fair value of RSUs vested during the three months ended March 31, 2013 and 2012 was $17,672 and $18,517, respectively.
Performance Share Units
PSUs granted to employees were 408,808 and 407,506 for the three months ended March 31, 2013 and 2012, respectively. The compensation expense recorded related to PSUs was $1,942 and $3,474 for the three months ended March 31, 2013 and 2012, respectively. During the three months ended March 31, 2013, portions of the compensation expense recorded in 2012 were reversed since the Companys level of actual performance as measured against pre-established performance goals had declined. The related total income tax benefit was $668 and $1,218 for the three months ended March 31, 2013 and 2012, respectively. The weighted average grant date fair value for PSUs granted during the three months ended March 31, 2013 and 2012 was $44.22 and $41.68, respectively.
As of March 31, 2013, there was $26,933 of unrecognized compensation cost related to outstanding PSUs. That cost is expected to be recognized over a weighted-average period of 0.99 years.
The fair value of PSUs with market conditions was estimated on the date of grant using a Monte Carlo simulation model, which utilizes multiple variables that determine the probability of satisfying the market condition stipulated in the award. Expected volatilities for awards issued during the three months ended March 31, 2013 and 2012 were based on the historical stock prices of the Companys stock and peer insurance group. The expected term for grants issued during the three months ended March 31, 2013 and 2012 was assumed to equal the average of the vesting period of the PSUs. The risk-free rate was based on the U.S. Treasury yield curve in effect at the time of grant.
Long-Term Incentive Plan
Prior to the approval of the ALTEIP, share based awards were granted under the 2004 Assurant Long-Term Incentive Plan (ALTIP), which authorized the granting of up to 10,000,000 new shares of the Companys common stock to employees and officers under the ALTIP, Business Value Rights Program (BVR) and CEO Equity Grants Program. Under the ALTIP, the Company was authorized to grant restricted stock and SARs. Since May 2008, no new grants have been made under this plan and the impact of these grants on the consolidated financial statements is immaterial.
Employee Stock Purchase Plan
Under the Employee Stock Purchase Plan (ESPP), the Company is authorized to issue up to 5,000,000 new shares to employees who are participants in the ESPP. Eligible employees can purchase shares at a 10% discount applied to the lower of the closing price of the common stock on the first or last day of the offering period.
29
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
In January 2013, the Company issued 107,535 shares at a discounted price of $31.23 for the offering period of July 1, 2012 through December 31, 2012. In January 2012, the Company issued 103,243 shares at a discounted price of $32.98 for the offering period of July 1, 2011 through December 31, 2011.
The compensation expense recorded related to the ESPP was $249 and $379 for the three months ended March 31, 2013 and 2012, respectively.
The fair value of each award under the ESPP was estimated at the beginning of each offering period using the Black-Scholes option-pricing model. Expected volatilities are based on implied volatilities from traded options on the Companys stock and the historical volatility of the Companys stock. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is based on the current annualized dividend and share price as of the grant date.
9. Stock Repurchase
The following table shows the shares repurchased during the periods indicated:
Period in 2013 |
Number of Shares Purchased |
Average Price Paid Per Share |
Total Number
of Shares Purchased as Part of Publicly Announced Programs |
|||||||||
January |
0 | $ | 0 | 0 | ||||||||
February |
0 | 0 | 0 | |||||||||
March |
600,000 | 44.28 | 600,000 | |||||||||
|
|
|
|
|
|
|||||||
Total |
600,000 | $ | 44.28 | 600,000 | ||||||||
|
|
|
|
|
|
On May 14, 2012, the Companys Board of Directors authorized the Company to repurchase up to an additional $600,000 of its outstanding common stock.
As of December 31, 2012, there was $502,900 remaining under the total repurchase authorization. During the three months ended March 31, 2013, the Company repurchased 600,000 shares of the Companys outstanding common stock at a cost of $26,554, exclusive of commissions, leaving $476,345 remaining under the total repurchase authorization at March 31, 2013.
30
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
10. Earnings Per Common Share
The following table presents net income, the weighted average common shares used in calculating basic earnings per common share (EPS) and those used in calculating diluted EPS for each period presented below.
Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Numerator |
||||||||
Net income |
$ | 117,780 | $ | 163,260 | ||||
Deduct dividends paid |
(16,789 | ) | (15,941 | ) | ||||
|
|
|
|
|||||
Undistributed earnings |
$ | 100,991 | $ | 147,319 | ||||
|
|
|
|
|||||
Denominator |
||||||||
Weighted average shares outstanding used in basic earnings per share calculations |
79,984,576 | 88,772,845 | ||||||
Incremental common shares from : |
||||||||
SARs |
73,515 | 156,735 | ||||||
PSUs |
876,082 | 1,139,517 | ||||||
ESPPs |
12,476 | 0 | ||||||
|
|
|
|
|||||
Weighted average shares used in diluted earnings per share calculations |
80,946,649 | 90,069,097 | ||||||
|
|
|
|
|||||
Earnings per common share - Basic |
||||||||
Distributed earnings |
$ | 0.21 | $ | 0.18 | ||||
Undistributed earnings |
1.26 | 1.66 | ||||||
|
|
|
|
|||||
Net income |
$ | 1.47 | $ | 1.84 | ||||
|
|
|
|
|||||
Earnings per common share Diluted |
||||||||
Distributed earnings |
$ | 0.21 | $ | 0.18 | ||||
Undistributed earnings |
1.25 | 1.63 | ||||||
|
|
|
|
|||||
Net income |
$ | 1.46 | $ | 1.81 | ||||
|
|
|
|
Average SARs totaling 222 for the three months ended March 31, 2012, were outstanding but were anti-dilutive and thus not included in the computation of diluted EPS under the treasury stock method. No SARs were anti-dilutive for the three months ended March 31, 2013.
Average PSUs totaling 81,762 for the three months ended March 31, 2013, were also outstanding but were anti-dilutive and thus not included in the computation of diluted EPS under the treasury stock method. No PSUs were anti-dilutive for the three months ended March 31, 2012.
31
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
11. Retirement and Other Employee Benefits
The components of net periodic benefit cost for the Companys qualified pension benefits plan, nonqualified pension benefits plan and retirement health benefits plan for the three months ended March 31, 2013 and 2012 were as follows:
Qualified Pension Benefits |
Nonqualified Pension Benefits (1) |
Retirement Health Benefits |
||||||||||||||||||||||
For the Three Months Ended March 31, |
For the Three
Months Ended March 31, |
For the Three
Months Ended March 31, |
||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||
Service cost |
$ | 9,300 | $ | 8,125 | $ | 1,150 | $ | 925 | $ | 850 | $ | 700 | ||||||||||||
Interest cost |
7,575 | 8,150 | 1,200 | 1,350 | 825 | 875 | ||||||||||||||||||
Expected return on plan assets |
(11,075 | ) | (10,100 | ) | 0 | 0 | (700 | ) | (775 | ) | ||||||||||||||
Amortization of prior service cost |
0 | 25 | 175 | 175 | (225 | ) | (225 | ) | ||||||||||||||||
Amortization of net loss |
6,825 | 4,725 | 1,600 | 1,050 | 0 | 0 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net periodic benefit cost |
$ | 12,625 | $ | 10,925 | $ | 4,125 | $ | 3,500 | $ | 750 | $ | 575 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | The Companys nonqualified plan is unfunded. |
Our qualified pension benefits plan (the Plan) was under-funded by $77,533 and $107,666 (based on the fair value of Plan assets compared to the projected benefit obligation) at March 31, 2013 and December 31, 2012, respectively. This equates to a 90% and 87% funded status at March 31, 2013 and December 31, 2012, respectively. The change in under-funded projected benefit obligation status is mainly due to an increase in the discount rate used to determine the projected benefit obligation and favorable investment returns. During the first three months of 2013, $12,500 in cash was contributed to the Plan. Additional cash, up to $37,500, is expected to be contributed to the Plan over the remainder of 2013.
12. Segment Information
The Company has five reportable segments, which are defined based on the nature of the products and services offered: Assurant Solutions, Assurant Specialty Property, Assurant Health, Assurant Employee Benefits, and Corporate & Other. Assurant Solutions provides warranties and service contracts, pre-funded funeral insurance, debt protection administration, and credit-related insurance. Assurant Specialty Property provides lender-placed homeowners insurance, manufactured housing homeowners insurance and renters insurance and related products. Assurant Health provides individual health and small employer group health insurance. Assurant Employee Benefits primarily provides group dental insurance, group disability insurance, group life insurance and group vision and supplemental insurance. Corporate & Other includes activities of the holding company, financing and interest expenses, net realized gains (losses) on investments and interest income earned from short-term investments held. Corporate & Other also includes the amortization of deferred gains associated with the sales of Fortis Financial Group and Long-Term Care through reinsurance agreements.
The Company evaluates performance of the operating segments based on segment income (loss) after-tax excluding realized gains (losses) on investments. The Company determines reportable segments in a manner consistent with the way the Chief Operating Decision Maker makes operating decisions and assesses performance.
32
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
The following tables summarize selected financial information by segment:
Three Months Ended March 31, 2013 | ||||||||||||||||||||||||
Solutions | Specialty Property |
Health | Employee Benefits |
Corporate & Other |
Consolidated | |||||||||||||||||||
Revenues |
||||||||||||||||||||||||
Net earned premiums |
$ | 689,500 | $ | 529,799 | $ | 379,209 | $ | 251,940 | $ | 0 | $ | 1,850,448 | ||||||||||||
Net investment income |
95,229 | 25,762 | 9,347 | 30,138 | 5,509 | 165,985 | ||||||||||||||||||
Net realized gains on investments |
0 | 0 | 0 | 0 | 13,038 | 13,038 | ||||||||||||||||||
Amortization of deferred gain on disposal of businesses |
0 | 0 | 0 | 0 | 4,092 | 4,092 | ||||||||||||||||||
Fees and other income |
79,112 | 26,187 | 6,076 | 5,629 | 56 | 117,060 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
863,841 | 581,748 | 394,632 | 287,707 | 22,695 | 2,150,623 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Benefits, losses and expenses |
||||||||||||||||||||||||
Policyholder benefits |
211,737 | 186,723 | 275,495 | 183,406 | 0 | 857,361 | ||||||||||||||||||
Amortization of deferred acquisition costs and value of business acquired |
286,041 | 89,939 | 80 | 6,729 | 0 | 382,789 | ||||||||||||||||||
Underwriting, general and administrative expenses |
313,569 | 155,340 | 104,589 | 88,383 | 27,090 | 688,971 | ||||||||||||||||||
Interest expense |
0 | 0 | 0 | 0 | 15,078 | 15,078 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total benefits, losses and expenses |
811,347 | 432,002 | 380,164 | 278,518 | 42,168 | 1,944,199 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment income (loss) before provision (benefit) for income tax |
52,494 | 149,746 | 14,468 | 9,189 | (19,473 | ) | 206,424 | |||||||||||||||||
Provision (benefit) for income taxes |
17,587 | 55,502 | 19,811 | 3,106 | (7,362 | ) | 88,644 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment income (loss) after tax |
$ | 34,907 | $ | 94,244 | $ | (5,343 | ) | $ | 6,083 | $ | (12,111 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income |
$ | 117,780 | ||||||||||||||||||||||
|
|
As of March 31, 2013 | ||||||||||||||||||||||||
Segment Assets: |
||||||||||||||||||||||||
Segment assets, excluding goodwill |
$ | 12,405,642 | $ | 4,025,765 | $ | 866,729 | $ | 2,358,616 | $ | 9,186,167 | $ | 28,842,919 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Goodwill |
638,621 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total Assets |
$ | 29,481,540 | ||||||||||||||||||||||
|
|
33
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Three Months Ended March 31, 2012 | ||||||||||||||||||||||||
Solutions | Specialty Property |
Health | Employee Benefits |
Corporate & Other |
Consolidated | |||||||||||||||||||
Revenues |
||||||||||||||||||||||||
Net earned premiums |
$ | 626,948 | $ | 484,200 | $ | 407,473 | $ | 258,440 | $ | 0 | $ | 1,777,061 | ||||||||||||
Net investment income |
99,311 | 24,701 | 11,128 | 31,933 | 5,222 | 172,295 | ||||||||||||||||||
Net realized gains on investments |
0 | 0 | 0 | 0 | 7,544 | 7,544 | ||||||||||||||||||
Amortization of deferred gain on disposal of businesses |
0 | 0 | 0 | 0 | 4,621 | 4,621 | ||||||||||||||||||
Fees and other income |
72,440 | 24,139 | 7,755 | 7,008 | 61 | 111,403 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
798,699 | 533,040 | 426,356 | 297,381 | 17,448 | 2,072,924 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Benefits, losses and expenses |
||||||||||||||||||||||||
Policyholder benefits |
209,808 | 155,710 | 302,484 | 188,356 | 0 | 856,358 | ||||||||||||||||||
Amortization of deferred acquisition costs and value of business acquired |
253,778 | 81,729 | 77 | 6,174 | 0 | 341,758 | ||||||||||||||||||
Underwriting, general and administrative expenses |
269,399 | 125,283 | 104,274 | 89,175 | 21,953 | 610,084 | ||||||||||||||||||
Interest expense |
0 | 0 | 0 | 0 | 15,076 | 15,076 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total benefits, losses and expenses |
732,985 | 362,722 | 406,835 | 283,705 | 37,029 | 1,823,276 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment income (loss) before provision (benefit) for income tax |
65,714 | 170,318 | 19,521 | 13,676 | (19,581 | ) | 249,648 | |||||||||||||||||
Provision (benefit) for income taxes |
22,314 | 57,314 | 7,906 | 4,612 | (5,758 | ) | 86,388 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Segment income (loss) after tax |
$ | 43,400 | $ | 113,004 | $ | 11,615 | $ | 9,064 | $ | (13,823 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income |
$ | 163,260 | ||||||||||||||||||||||
|
|
As of December 31, 2012 | ||||||||||||||||||||||||
Segment Assets: |
||||||||||||||||||||||||
Segment assets, excluding goodwill |
$ | 12,342,077 | $ | 4,207,746 | $ | 882,731 | $ | 2,366,097 | $ | 8,507,242 | $ | 28,305,893 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Goodwill |
640,714 | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Total assets |
$ | 28,946,607 | ||||||||||||||||||||||
|
|
34
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
13. Commitments and Contingencies
In the normal course of business, letters of credit are issued primarily to support reinsurance arrangements in which the Company is the reinsurer. These letters of credit are supported by commitments under which the Company is required to indemnify the financial institution issuing the letter of credit if the letter of credit is drawn. The Company had $21,042 and $19,760 of letters of credit outstanding as of March 31, 2013 and December 31, 2012, respectively.
On March 21, 2013, the Company and two of its wholly owned subsidiaries in the Assurant Specialty Property segment, American Security Insurance Company (ASIC) and American Bankers Insurance Company of Florida (ABIC), reached an agreement with the New York Department of Financial Services (the NYDFS) regarding the Companys lender-placed insurance business in the State of New York. Under the terms of the agreement, and without admitting or denying any wrongdoing, ASIC has made a $14,000 settlement payment to the NYDFS. In addition, among other things, ASIC and ABIC have agreed to modify certain business practices in accordance with new regulations expected to be issued by the NYDFS that will apply to all New York-licensed lender-placed insurers of properties in the state; file our new lender-placed program and new rates in New York; and establish a refund opportunity program to be administered by an independent third party, through which certain New York property owners with ASIC or ABIC policies issued on or after January 1, 2008 may be eligible, for a 90-day period and upon meeting specific criteria, for a refund of a portion of premiums they paid.
As previously disclosed, the Company is involved in a variety of legal and regulatory actions in the ordinary course relating to its current and past business operations, both as a plaintiff and a defendant, and may from time to time become involved in other such actions. In particular, the Company is a defendant in class actions in a number of jurisdictions regarding its lender-placed insurance programs for hazard, flood and wind. These cases allege a variety of claims under a number of legal theories. The plaintiffs seek premium refunds and other relief. The Company continues to vigorously defend these actions.
Although the Company cannot predict the outcome of any action, it is possible that such outcome could have a material adverse effect on the Companys consolidated results of operations or cash flows for an individual reporting period. However, based on currently available information, management does not believe that any pending matter is likely to have a material adverse effect, individually or in the aggregate, on the Companys financial condition.
14. Income Taxes
During the three months ended March 31, 2013, the Company increased its estimated amount of compensation expenses that are non-tax deductible under the Affordable Care Act. Due to this change in estimate, the Company recorded $10,205 of income tax expense, which increased the consolidated effective tax rate by 490 basis points.
15. Catastrophe Bond Program
On May 5, 2009, certain of the Companys subsidiaries (the Subsidiaries) entered into two reinsurance agreements with Ibis Re Ltd., an independent special purpose reinsurance company domiciled in the Cayman Islands (Ibis Re). The Ibis Re agreements provide up to $150,000 of reinsurance coverage for protection against losses over a three-year period from individual hurricane events in Hawaii and along the Gulf and Eastern Coasts of the United States. Ibis Re financed the property catastrophe reinsurance coverage by issuing catastrophe bonds in an aggregate amount of $150,000 to unrelated investors (the Series 2009-1 Notes). The agreements expired in May 2012.
On April 27, 2010, the Subsidiaries entered into two additional reinsurance agreements with Ibis Re providing up to $150,000 of reinsurance coverage for protection against losses over a three-year period from individual hurricane events in Hawaii and along the Gulf and Eastern Coasts of the United States. The agreements expire in May 2013. Ibis Re financed the property catastrophe reinsurance coverage by issuing catastrophe bonds in an aggregate amount of $150,000 to unrelated investors (the Series 2010-1 Notes).
On January 30, 2012, the Subsidiaries entered into two reinsurance agreements with Ibis Re II Ltd. (Ibis Re II). Ibis Re II, incorporated on December 2, 2011, is an independent special purpose reinsurance company domiciled in the Cayman Islands. The
35
Assurant, Inc. Notes to Consolidated Financial Statements (unaudited) Three Months Ended March 31, 2013 and 2012 (In thousands, except number of shares and per share amounts) |
Ibis Re II agreements provide up to $130,000 of reinsurance coverage for protection against losses over a three-year period from individual hurricane events in Hawaii, Puerto Rico, and along the Gulf and Eastern Coasts of the United States. The agreements expire in February 2015. Ibis Re II financed the property catastrophe reinsurance coverage by issuing $130,000 in catastrophe bonds to unrelated investors (the Series 2012-1 Notes). The Series 2012-1 Notes replace the Series 2009-1 Notes.
Upon expiration of the Series 2009-1 Notes, the remaining $280,000 of coverage represents approximately 20% of the expected first event coverage (net of reimbursements of the Florida Hurricane Catastrophe Fund) purchased by the Company in excess of the Companys anticipated retention.
Under the terms of these reinsurance agreements, the Subsidiaries are obligated to pay annual reinsurance premiums to Ibis Re and Ibis Re II for the reinsurance coverage. The reinsurance agreements with Ibis Re and Ibis Re II utilize a dual trigger that is based upon an index that is created by applying predetermined percentages to insured industry losses in each state in the covered area as reported by an independent party and the Subsidiaries covered losses incurred. Reinsurance contracts that have a separate, pre-identified variable (e.g., a loss-based index) are accounted for as reinsurance if certain conditions are met. In the case of the reinsurance agreements with Ibis Re and Ibis Re II, these conditions were met, thus the Company accounted for them as reinsurance in accordance with the guidance for reinsurance contracts.
Amounts payable to the Subsidiaries under the reinsurance agreements will be determined by the index-based losses, which are designed to approximate the Subsidiaries actual losses from any covered event. The amount of actual losses and index losses from any covered event may differ. For each covered event, Ibis Re and Ibis Re II pay the Subsidiaries the lesser of the covered index-based losses or the Subsidiaries actual losses. The principal amount of the catastrophe bonds will be reduced by any amounts paid to the Subsidiaries under the reinsurance agreements. The Subsidiaries have not incurred any losses subject to the reinsurance agreements since their inception.
As of March 31, 2013, the Company had not ceded any losses to Ibis Re or Ibis Re II.
As with any reinsurance agreement, there is credit risk associated with collecting amounts due from reinsurers. With regard to the Series 2010-1 Notes and Series 2012-1 Notes, the credit risk is mitigated by two reinsurance trust accounts for each Series. Each reinsurance trust account has been funded by Ibis Re (Series 2010-1 Notes) or Ibis Re II (Series 2012-1 Notes) with money market funds that invest solely in direct government obligations backed by the U.S. government with maturities of no more than 13 months. The money market funds must have a principal stability rating of at least AAA by Standard & Poors.
At the time the agreements were entered into with Ibis Re and Ibis Re II, the Company evaluated the applicability of the accounting guidance that addresses variable interest entities (VIEs). Entities which do not have sufficient equity at risk to allow the entity to finance its activities without additional financial support or in which the equity investors, as a group, do not have the characteristic of a controlling financial interest are referred to as VIEs. A VIE is consolidated by the variable interest holder that is determined to have the controlling financial interest (primary beneficiary) as a result of having both the power to direct the activities of a VIE that most significantly impact the VIEs economic performance and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. The Company determines whether it is the primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIEs capital structure, contractual terms, nature of the VIEs operations and purpose and the Companys relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE. The Company reassesses its VIE determination with respect to an entity on an ongoing basis.
As a result of the evaluation of the reinsurance agreements with Ibis Re and Ibis Re II, the Company concluded that Ibis Re and Ibis Re II are VIEs. However, while Ibis Re and Ibis Re II are VIEs, the Company concluded that it does not have a significant variable interest in Ibis Re or Ibis Re II as the variability in results, caused by the reinsurance agreements, is expected to be absorbed entirely by the bondholders and the Company is not entitled to any residual amounts. Accordingly, the Company is not the primary beneficiary of Ibis Re or Ibis Re II and does not consolidate the entities in the Companys financial statements.
36
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
(Dollar amounts in thousands)
This Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A) addresses the financial condition of Assurant, Inc. and its subsidiaries (which we refer to collectively as Assurant or the Company) as of March 31, 2013, compared with December 31, 2012, and our results of operations for the three months ended March 31, 2013 and 2012. This discussion should be read in conjunction with our MD&A and annual audited consolidated financial statements as of December 31, 2012 included in our Annual Report on Form 10-K for the year ended December 31, 2012 filed with the U.S. Securities and Exchange Commission (the SEC) and the March 31, 2013 unaudited consolidated financial statements and related notes included elsewhere in this Form 10-Q. The 2012 Annual Report on Form 10-K, First Quarter 2013 Form 10-Q, and other documents related to the Company are available free of charge through the SEC website at www.sec.gov and through our website at www.assurant.com.
Some of the statements in this MD&A and elsewhere in this report, particularly those anticipating future financial performance, business prospects, growth and operating strategies and similar matters, are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these statements by the fact that they may use words such as will, may, anticipates, expects, estimates, projects, intends, plans, believes, targets, forecasts, potential, approximately, or the negative version of those words and other words and terms with a similar meaning. Any forward-looking statements contained in this report are based upon our historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. Our actual results might differ materially from those projected in the forward-looking statements. The Company undertakes no obligation to update or review any forward-looking statement, whether as a result of new information, future events or other developments.
In addition to the factors described under Critical Factors Affecting Results, the following risk factors could cause our actual results to differ materially from those currently estimated by management:
(i) | actions by governmental agencies or government sponsored entities or other circumstances, including pending regulatory matters affecting our lender-placed insurance business, that could result in reductions of the premium rates we charge, increases in the claims we pay, fines or penalties, or other expenses; |
(ii) | the effects of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, and the rules and regulations thereunder (together the Affordable Care Act), on our health and employee benefits businesses; |
(iii) | loss of significant client relationships, distribution sources and contracts; |
(iv) | unfavorable outcomes in litigation and/or regulatory investigations that could negatively affect our business and reputation; |
(v) | current or new laws and regulations that could increase our costs and decrease our revenues; |
(vi) | a decline in our credit or financial strength ratings (including the risk of ratings downgrades in the insurance industry); |
(vii) | deterioration in the Companys market capitalization compared to its book value that could result in further impairment of goodwill; |
(viii) | risks related to outsourcing activities; |
(ix) | failure to attract and retain sales representatives or key managers; |
(x) | losses due to natural or man-made catastrophes; |
(xi) | general global economic, financial market and political conditions (including difficult conditions in financial, capital, credit and currency markets, the global economic slowdown, fluctuations in interest rates or a prolonged period of low interest rates, monetary policies, unemployment and inflationary pressure); |
(xii) | inadequacy of reserves established for future claims; |
(xiii) | failure to predict or manage benefits, claims and other costs; |
(xiv) | uncertain tax positions and unexpected tax liabilities; |
(xv) | fluctuations in exchange rates and other risks related to our international operations; |
(xvi) | unavailability, inadequacy and unaffordable pricing of reinsurance coverage; |
(xvii) | significant competitive pressures in our business; |
(xviii) | diminished value of invested assets in our investment portfolio (due to, among other things, volatility in financial markets; the global economic slowdown; credit, currency and liquidity risk; other than temporary impairments and increases in interest rates); |
37
(xix) | insolvency of third parties to whom we have sold or may sell businesses through reinsurance or modified co-insurance; |
(xx) | inability of reinsurers to meet their obligations; |
(xxi) | credit risk of some of our agents in Assurant Specialty Property and Assurant Solutions; |
(xxii) | cyber security threats and cyber attacks; |
(xxiii) | failure to effectively maintain and modernize our information systems; |
(xxiv) | data breaches compromising client information and privacy; |
(xxv) | failure to find and integrate suitable acquisitions and new ventures; |
(xxvi) | inability of our subsidiaries to pay sufficient dividends; |
(xxvii) | failure to provide for succession of senior management and key executives; and |
(xxviii) | cyclicality of the insurance industry. |
For a more detailed discussion of the risk factors that could affect our actual results, please refer to Item 1ARisk Factors and Item 7MD&A Critical Factors Affecting Results in our 2012 Annual Report on Form 10-K and in this First Quarter 2013 Form 10-Q.
Executive Summary
Assurant has five reportable segments. Our four operating segments are Assurant Solutions, Assurant Specialty Property, Assurant Health, and Assurant Employee Benefits. These operating segments partner with clients who are leaders in their industries in the United States of America (the U.S.) and select worldwide markets. The operating segments provide warranties and service contracts, pre-funded funeral insurance, debt protection administration, credit-related insurance, lender-placed homeowners insurance, renters insurance and related products, manufactured housing homeowners insurance, individual health and small employer group health insurance, group dental insurance, group disability insurance and reinsurance, group life insurance, group vision and supplemental insurance.
Our fifth segment, Corporate & Other, includes activities of the holding company, financing and interest expenses, net realized gains and losses on investments, interest income earned from short-term investments held and additional costs associated with excess of loss reinsurance programs reinsured and ceded to certain subsidiaries in the London market between 1995 and 1997. Corporate & Other also includes the amortization of deferred gains associated with the sales of Fortis Financial Group and Long-Term Care through reinsurance agreements.
The following discussion relates to the three months ended March 31, 2013 (First Quarter 2013) and the three months ended March 31, 2012 (First Quarter 2012).
Consolidated net income decreased 28% to $117,780 in First Quarter 2013 compared with $163,260 for First Quarter 2012. This decrease was primarily driven by declines at our Assurant Specialty Property and Assurant Health segments further described below.
Assurant Solutions net income declined $8,493, or 20%, to $34,907 in First Quarter 2013 compared with $43,400 in First Quarter 2012. Higher mortality rates in our preneed business and the previously disclosed loss of a mobile client contributed to this decline.
Domestic net earned premiums and fees increased, primarily due to accelerated growth at an existing service contract client, as well as growth in our vehicle service contract business as U.S. auto sales continued to rebound. This growth offset declines in other accounts, including the previously disclosed mobile client loss. Our domestic combined ratio increased slightly to 96.9% for First Quarter 2013 from 96.3% in First Quarter 2012, but still below our long-term target of 98.0% due to expense savings actions taken in 2012.
The international combined ratio improved to 102.3% in First Quarter 2013 from 103.2% in First Quarter 2012, excluding a one-time premium tax liability release of $3,700 in Canada in First Quarter 2012. The improvement was primarily due to continued expansion in Latin America across all products and expense management efforts in Europe. Given the continued challenging macroeconomic conditions in the United Kingdom, we plan to reduce their expenses further to meet our commitment of profitability in the region by third quarter of this year. These expense initiatives, together with anticipated growth in Latin America, are expected to drive continued improvement in the international combined ratio over the course of 2013.
Overall, we expect modest premium growth at Assurant Solutions in 2013, reflecting growth in our domestic and international service contract business.
At Assurant Specialty Property, net income declined 17% to $94,244 in First Quarter 2013 from $113,004 in First Quarter 2012. The decrease was primarily driven by a $14,000 settlement agreement with the New York Department of Financial Services (the NYDFS), which is discussed further below, and $10,013 (after-tax) of reportable catastrophe losses from hailstorms in the Southeast and unfavorable loss development from Superstorm Sandy. In addition, significant loan volume growth during the past year contributed to higher expenses as we expanded capacity to service these new loans.
38
Net earned premiums and fees increased by 9% due to premium production from lender-placed insurance loan portfolios added in 2012 and contributions from multi-family housing products. Our placement rate in First Quarter 2013 remained elevated at 2.89% compared with 2.84% in First Quarter 2012 driven by the loan portfolios acquired in 2012. We added 1,700,000 loans in First Quarter 2013 and expect to add another 900,000 loans over the next two quarters. These new loans will begin to produce net earned premiums later this year, and we expect this growth to help sustain our net earned premiums despite the expected decline in placement rates over the course of 2013.
As we have disclosed, we continue to engage in discussions with various state and federal regulatory departments regarding our lender-placed insurance program. During First Quarter 2013, we reached a settlement with the NYDFS regarding our lender-placed insurance program in that state. Please refer to Assurant Specialty Propertys results of operations section further below in this Item 2 for details on this settlement. In addition, the Federal Housing Finance Agency (the FHFA) issued a notice of several potential changes to lender-placed insurance on loans owned or guaranteed by government sponsored entities, such as the elimination of commissions and servicer affiliated quota share reinsurance. We anticipate that the FHFA will publish final regulations later this year.
In 2012, we began a multi-phased roll-out of our new next generation product to respond to the changed environment following the housing crisis, and we expect it to be available in 28 states by the end of the second quarter. We filed our new product forms and rates in Florida and New York, which are currently undergoing review.
Overall, we expect Assurant Specialty Propertys net earned premiums to increase slightly from 2012 due to growth in our lender-placed insurance portfolio and multi-family housing products. We expect overall results to continue to be affected by placement rate trends, premium rate changes, loan portfolio activity, client renewals, and catastrophe losses. We expect our expense ratio, excluding the effect of the NYDFS settlement, to increase in 2013, primarily reflecting increased costs to support new loan portfolios and customer service enhancements. We also expect our non-catastrophe loss ratio to increase due to anticipated higher frequency of such losses compared to 2012.
Assurant Health results declined to a net loss of $5,343 for First Quarter 2013 compared with net income of $11,615 in First Quarter 2012. This decline is primarily due to an increased estimate of non tax-deductible compensation expenses under the Affordable Care Act, which resulted in a $10,205 increase to our income tax expense in First Quarter 2013.
Net earned premiums in our individual markets and small employer group business decreased. However, recent sales momentum has moderated the rate of this decline compared to past quarters. Our individual major medical product sales increased due to our network partnership with Aetna Signature Administrators®. Sales of our supplemental and affordable choice products also increased.
We expect ongoing changes related to healthcare reform to continue to affect this business in 2013. We anticipate our effective tax rate to remain very high due to higher non-deductible compensation expenses. We also expect continued expense management efforts in this business. Overall, we expect net earned premiums and fees to decline, reflecting the continued shift to lower premium products in our individual medical business.
At Assurant Employee Benefits, net income declined 33% to $6,083 in First Quarter 2013 from $9,064 in First Quarter 2012. The decrease was primarily driven by lower net investment income and a reduction in the discount rate for new long-term disability claim reserves. Similar to our preneed business, we experienced higher mortality rates in First Quarter 2013, which offset continued favorable dental experience.
Net earned premiums and fees declined slightly in First Quarter 2013 compared with First Quarter 2012 primarily due to the residual impact of the previously disclosed loss of two assumed disability clients last year. However, sales increased in First Quarter 2013, driven by growth across all major products. Overall, for 2013, we expect net earned premiums and fees to be consistent with 2012 due to continued growth in voluntary products.
39
Critical Factors Affecting Results and Liquidity
Our results depend on the appropriateness of our product pricing, underwriting and the accuracy of our methodology for the establishment of reserves for future policyholder benefits and claims, returns on and values of invested assets and our ability to manage our expenses. Factors affecting these items, including unemployment, difficult conditions in financial markets and the global economy, may have a material adverse effect on our results of operations or financial condition. For more information on these factors, see Item 1ARisk Factors and Item 7MD&A Critical Factors Affecting Results in our 2012 Annual Report on Form 10-K.
Management believes the Company will have sufficient liquidity to satisfy its needs over the next twelve months including the ability to pay interest on our debt and dividends on our common stock.
For the three months ended March 31, 2013, net cash provided by operating activities, including the effect of exchange rate changes on cash and cash equivalents, totaled $43,560; net cash used in investing activities totaled $18,511 and net cash provided by financing activities totaled $670,172. We had $1,604,625 in cash and cash equivalents as of March 31, 2013. Please see Liquidity and Capital Resources, below for further details.
Critical Accounting Policies and Estimates
Our 2012 Annual Report on Form 10-K described the accounting policies and estimates that are critical to the understanding of our results of operations, financial condition and liquidity. The accounting policies and estimation process described in the 2012 Annual Report on Form 10-K were consistently applied to the unaudited interim consolidated financial statements for First Quarter 2013.
The Assurant Health loss ratio reported on page 46 (the GAAP loss ratio) differs from the loss ratio calculated under the minimum medical loss ratio (MLR). The most significant differences include the fact that the MLR is calculated separately by state and legal entity; the MLR calculation includes credibility adjustments for each entity, which are not applicable to the GAAP loss ratio; the MLR calculation applies only to some of our health insurance products, while the GAAP loss ratio applies to the entire portfolio, including products not governed by the Affordable Care Act; the MLR includes quality improvement expenses, taxes and fees; changes in reserves are treated differently in the MLR calculation; and the MLR premium rebate amounts are considered adjustments to premiums for GAAP reporting whereas they are reported as additions to incurred claims in the MLR rebate estimate calculations.
Assurant Health has estimated its First Quarter 2013 impact of this regulation based on definitions and calculation methodologies outlined in the Interim Final Regulation from HHS released December 1, 2010 with Technical Corrections released December 29, 2010 and the HHS Final Regulation released December 7, 2011. An estimate was based on separate projection models for individual medical and small group business using projections of expected premiums, claims, and enrollment by state, legal entity and market for medical business subject to MLR requirements for the MLR reporting year. In addition, the projection models include quality improvement expenses, state assessments and taxes.
40
Assurant Consolidated
Overview
The table below presents information regarding our consolidated results of operations:
For the Three Months
Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net earned premiums |
$ | 1,850,448 | $ | 1,777,061 | ||||
Net investment income |
165,985 | 172,295 | ||||||
Net realized gains on investments |
13,038 | 7,544 | ||||||
Amortization of deferred gain on disposal of businesses |
4,092 | 4,621 | ||||||
Fees and other income |
117,060 | 111,403 | ||||||
|
|
|
|
|||||
Total revenues |
2,150,623 | 2,072,924 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Policyholder benefits |
857,361 | 856,358 | ||||||
Selling, underwriting and general expenses (1) |
1,071,760 | 951,842 | ||||||
Interest expense |
15,078 | 15,076 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
1,944,199 | 1,823,276 | ||||||
|
|
|
|
|||||
Income before provision for income taxes |
206,424 | 249,648 | ||||||
Provision for income taxes |
88,644 | 86,388 | ||||||
|
|
|
|
|||||
Net income |
$ | 117,780 | $ | 163,260 | ||||
|
|
|
|
(1) | Includes amortization of deferred acquisition costs (DAC) and value of business acquired (VOBA). |
The following discussion provides a general overall analysis of how the consolidated results were affected by our four operating segments and our Corporate and Other segment for First Quarter 2013 and First Quarter 2012. Please see the discussion that follows, for each of these segments, for a more detailed analysis of the fluctuations.
For The Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net Income
Net income decreased $45,480 or 28%, to $117,780 in First Quarter 2013, compared with $163,260 of net income for First Quarter 2012. The decline was primarily due to a $14,000 (non tax-deductible) settlement with the New York Department of Financial Services (NYDFS) and $10,013 (after-tax) of reportable catastrophe losses in our Assurant Specialty Property segment. There were no reportable catastrophe losses in First Quarter 2012. For additional detail on the NYDFS settlement, please refer to Assurant Specialty Propertys results of operations section further below in this Item 2. Also contributing to the decline was a $10,205 tax liability increase due to a change in estimated non-deductible compensation expense related to the Affordable Care Act.
41
Assurant Solutions
Overview
The tables below present information regarding Assurant Solutions segment results of operations:
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net earned premiums |
$ | 689,500 | $ | 626,948 | ||||
Net investment income |
95,229 | 99,311 | ||||||
Fees and other income |
79,112 | 72,440 | ||||||
|
|
|
|
|||||
Total revenues |
863,841 | 798,699 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Policyholder benefits |
211,737 | 209,808 | ||||||
Selling, underwriting and general expenses |
599,610 | 523,177 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
811,347 | 732,985 | ||||||
|
|
|
|
|||||
Segment income before provision for income taxes |
52,494 | 65,714 | ||||||
Provision for income taxes |
17,587 | 22,314 | ||||||
|
|
|
|
|||||
Segment net income |
$ | 34,907 | $ | 43,400 | ||||
|
|
|
|
|||||
Net earned premiums: |
||||||||
Domestic: |
||||||||
Credit |
$ | 41,732 | $ | 42,832 | ||||
Service contracts |
337,135 | 305,834 | ||||||
Other (1) |
20,541 | 14,045 | ||||||
|
|
|
|
|||||
Total domestic |
399,408 | 362,711 | ||||||
|
|
|
|
|||||
International: |
||||||||
Credit |
96,778 | 106,390 | ||||||
Service contracts |
168,172 | 129,061 | ||||||
Other (1) |
7,608 | 6,905 | ||||||
|
|
|
|
|||||
Total international |
272,558 | 242,356 | ||||||
|
|
|
|
|||||
Preneed |
17,534 | 21,881 | ||||||
|
|
|
|
|||||
Total |
$ | 689,500 | $ | 626,948 | ||||
|
|
|
|
|||||
Fees and other income: |
||||||||
Domestic: |
||||||||
Debt protection |
$ | 6,496 | $ | 6,965 | ||||
Service contracts |
33,420 | 31,015 | ||||||
Other (1) |
2,687 | 1,445 | ||||||
|
|
|
|
|||||
Total domestic |
42,603 | 39,425 | ||||||
|
|
|
|
|||||
International |
8,427 | 9,147 | ||||||
Preneed |
28,082 | 23,868 | ||||||
|
|
|
|
|||||
Total |
$ | 79,112 | $ | 72,440 | ||||
|
|
|
|
|||||
Gross written premiums (2): |
||||||||
Domestic: |
||||||||
Credit |
$ | 89,674 | $ | 93,242 | ||||
Service contracts |
440,322 | 391,694 | ||||||
Other (1) |
27,958 | 23,273 | ||||||
|
|
|
|
|||||
Total domestic |
557,954 | 508,209 | ||||||
|
|
|
|
|||||
International: |
||||||||
Credit |
242,547 | 247,329 | ||||||
Service contracts |
176,592 | 161,523 | ||||||
Other (1) |
11,564 | 11,050 | ||||||
|
|
|
|
|||||
Total international |
430,703 | 419,902 | ||||||
|
|
|
|
|||||
Total |
$ | 988,657 | $ | 928,111 | ||||
|
|
|
|
|||||
Preneed (face sales) |
$ | 229,478 | $ | 212,163 | ||||
|
|
|
|
|||||
Combined ratios (3): |
||||||||
Domestic |
96.9 | % | 96.3 | % | ||||
International |
102.3 | % | 101.7 | % |
42
(1) | This includes emerging products and run-off products lines. |
(2) | Gross written premiums does not necessarily translate to an equal amount of subsequent net earned premiums since Assurant Solutions reinsures a portion of its premiums to insurance subsidiaries of its clients. |
(3) | The combined ratio is equal to total benefits, losses and expenses divided by net earned premiums and fees and other income excluding the preneed business. |
For The Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net Income
Segment net income decreased $8,493, or 20%, to $34,907 for First Quarter 2013 from $43,400 for First
Quarter 2012, primarily due to higher mortality experience in our preneed business and the previously disclosed loss of a mobile client effective October 1, 2012. First Quarter 2012 included the recognition of a one-time premium tax liability release of $2,405 (after-tax) in Canada.
Total Revenues
Total revenues increased $65,142, or 8%, to $863,841 for First Quarter 2013 from $798,699 for First Quarter
2012. The increase was mainly the result of higher net earned premiums of $62,552 in both our domestic and international service contract businesses. Domestic service contract net earned premiums increased primarily from an existing service contract client as well as additional vehicle service contract clients partially offset by a previously disclosed loss of a mobile client. International service contract net earned premiums increased primarily due to growth in Latin America. Fees and other income increased $6,672, mostly driven by growth in our preneed business. These increases were partially offset by lower net investment income of $4,082 primarily due to lower investment yields.
Gross written premiums increased $60,546, or 7%, to $988,657 for First Quarter 2013 from $928,111 for First Quarter 2012. Domestic gross written premiums, mainly from our automotive and retail service contract business, increased $49,745 from both new and existing clients. Our international service contract business increased $15,069, primarily due to growth in Latin America from new and existing clients. These increases were partially offset by the unfavorable impact of changes in foreign exchange rates.
Preneed face sales increased $17,315, or 8%, to $229,478 for First Quarter 2013 from $212,163 for First Quarter 2012. This increase was mostly attributable to growth from our exclusive distribution partnership with Service Corporation International, the largest funeral provider in North America. This exclusive distribution partnership is effective through September 29, 2014.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses increased $78,362, or 11%, to $811,347 for First Quarter 2013 from $732,985 for First Quarter 2012. Policyholder benefits increased $1,929 primarily from higher mortality experience in our preneed business. Selling, underwriting and general expenses increased $76,433. Commissions, taxes, licenses and fees, of which amortization of DAC is a component, increased $85,412 due to higher net earned premiums in our domestic and international service contract businesses. General expenses decreased $8,979 primarily due to expense savings in our domestic credit and European businesses, partially offset by higher costs of supporting growth in Latin America.
43
Assurant Specialty Property
Overview
The tables below present information regarding Assurant Specialty Propertys segment results of operations:
For the Three Months Ended March 31, | ||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net earned premiums |
$ | 529,799 | $ | 484,200 | ||||
Net investment income |
25,762 | 24,701 | ||||||
Fees and other income |
26,187 | 24,139 | ||||||
|
|
|
|
|||||
Total revenues |
581,748 | 533,040 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Policyholder benefits |
186,723 | 155,710 | ||||||
Selling, underwriting and general expenses |
245,279 | 207,012 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
432,002 | 362,722 | ||||||
|
|
|
|
|||||
Segment income before provision for income taxes |
149,746 | 170,318 | ||||||
Provision for income taxes |
55,502 | 57,314 | ||||||
|
|
|
|
|||||
Segment net income |
$ | 94,244 | $ | 113,004 | ||||
|
|
|
|
|||||
Net earned premiums: |
||||||||
Homeowners (lender-placed and voluntary) |
$ | 362,477 | $ | 329,130 | ||||
Manufactured housing (lender-placed and voluntary) |
54,453 | 50,823 | ||||||
Other (1) |
112,869 | 104,247 | ||||||
|
|
|
|
|||||
Total |
$ | 529,799 | $ | 484,200 | ||||
|
|
|
|
|||||
Ratios: |
||||||||
Loss ratio (2) |
35.2 | % | 32.2 | % | ||||
Expense ratio (3) |
44.1 | % | 40.7 | % | ||||
Combined ratio (4) |
77.7 | % | 71.4 | % |
(1) | This primarily includes multi-family housing, lender-placed flood and miscellaneous insurance products. |
(2) | The loss ratio is equal to policyholder benefits divided by net earned premiums. |
(3) | The expense ratio is equal to selling, underwriting and general expenses divided by net earned premiums and fees and other income. |
(4) | The combined ratio is equal to total benefits, losses and expenses divided by net earned premiums and fees and other income. |
Regulatory Matters
On March 21, 2013, the Company and two of its wholly owned subsidiaries, American Security Insurance Company (ASIC) and American Bankers Insurance Company of Florida (ABIC), reached an agreement with the NYDFS regarding the Companys lender-placed insurance business in the State of New York. Under the terms of the agreement, and without admitting or denying any wrongdoing, ASIC made a $14,000 settlement payment to the NYDFS. In addition, among other things, ASIC and ABIC have agreed to modify certain business practices in accordance with new regulations expected to be issued by the NYDFS that will apply to all New York-licensed lender-placed insurers of properties in the state; file our new lender-placed program and new rates in New York; and establish a refund opportunity program to be administered by an independent third party, through which certain New York property owners with ASIC or ABIC policies issued on or after January 1, 2008 may be eligible, for a 90-day period and upon meeting specific criteria, for a refund of a portion of premiums they paid.
44
For The Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net Income
Segment net income decreased $18,760, or 17%, to $94,244 for First Quarter 2013 from $113,004 for First Quarter 2012. The decrease is primarily due to $10,013 (after-tax) of reportable catastrophe losses from hailstorms in the Southeast and unfavorable development from Superstorm Sandy, and an increase in selling, underwriting and general expenses which includes a $14,000 (non tax-deductible) settlement with the NYDFS and higher general expenses to support growth in lender-placed loan portfolios. Partially offsetting these items is an increase in net earned premiums, primarily in lender-placed homeowners insurance due to loan portfolios added in 2012 from both new and existing clients.
Total Revenues
Total revenues increased $48,708, or 9%, to $581,748 for First Quarter 2013 from $533,040 for First Quarter 2012, primarily driven by lender-placed homeowners and renters insurance business net earned premiums. Growth in lender-placed homeowners is primarily due to loan portfolios added in 2012 from both new and existing clients.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses increased $69,280 or 19%, to $432,002 for First Quarter 2013 from $362,722 for First Quarter 2012. The loss ratio increased 300 basis points primarily due to reportable catastrophe losses of $15,405 in First Quarter 2013 compared to no reportable catastrophe losses in First Quarter 2012. Included in First Quarter 2013 reportable catastrophe losses is $6,816 of additional adverse loss development related to Superstorm Sandy. Reportable catastrophe losses include only individual catastrophic events that generated losses to the Company in excess of $5,000, pre-tax and net of reinsurance. The expense ratio increased 340 basis points in First Quarter 2013 primarily due to the $14,000 settlement with the NYDFS, higher legal and regulatory expenses and an increase in operating costs to support business growth.
45
Assurant Health
Overview
The tables below present information regarding Assurant Healths segment results of operations:
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net earned premiums |
$ | 379,209 | $ | 407,473 | ||||
Net investment income |
9,347 | 11,128 | ||||||
Fees and other income |
6,076 | 7,755 | ||||||
|
|
|
|
|||||
Total revenues |
394,632 | 426,356 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Policyholder benefits |
275,495 | 302,484 | ||||||
Selling, underwriting and general expenses |
104,669 | 104,351 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
380,164 | 406,835 | ||||||
|
|
|
|
|||||
Segment income before provision for income taxes |
14,468 | 19,521 | ||||||
Provision for income taxes |
19,811 | 7,906 | ||||||
|
|
|
|
|||||
Segment net (loss) income |
$ | (5,343 | ) | $ | 11,615 | |||
|
|
|
|
|||||
Net earned premiums: |
||||||||
Individual markets |
$ | 281,606 | $ | 301,153 | ||||
Small employer group |
97,603 | 106,320 | ||||||
|
|
|
|
|||||
Total |
$ | 379,209 | $ | 407,473 | ||||
|
|
|
|
|||||
Insured lives by product line: |
||||||||
Individual |
679 | 603 | ||||||
Small employer group |
107 | 119 | ||||||
|
|
|
|
|||||
Total |
786 | 722 | ||||||
|
|
|
|
|||||
Ratios: |
||||||||
Loss ratio (1) |
72.6 | % | 74.2 | % | ||||
Expense ratio (2) |
27.2 | % | 25.1 | % | ||||
Combined ratio (3) |
98.7 | % | 98.0 | % |
(1) | The loss ratio is equal to policyholder benefits divided by net earned premiums. |
(2) | The expense ratio is equal to selling, underwriting and general expenses divided by net earned premiums and fees and other income. |
(3) | The combined ratio is equal to total benefits, losses and expenses divided by net earned premiums and fees and other income. |
The Affordable Care Act
Some provisions of the Affordable Care Act have taken effect already, and other provisions will become effective at various dates before the end of 2014. Given the sweeping nature of the changes represented by the Affordable Care Act, our results of operations and financial position could be materially adversely affected. For more information, see Item 1A, Risk FactorsRisk related to our industryReform of the health care industry could make our health insurance business unprofitable in our 2012 Annual Report on Form 10-K.
46
For the Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net (Loss) Income
Segment results decreased $16,958 to a net loss of $5,343 for First Quarter 2013 from net income of $11,615 for First Quarter 2012. The decrease was primarily attributable to a $10,205 tax liability increase in connection with the Affordable Care Act due to a change in estimated non-deductible compensation expense, and lower net earned premiums.
Total Revenues
Total revenues decreased $31,724, or 7%, to $394,632 for First Quarter 2013 from $426,356 for First Quarter 2012. Net earned premiums from our individual markets business decreased $19,547, or 6%, due to a decline in individual major medical policies, partially offset by increased sales of lower priced supplemental and affordable choice products and premium rate increases. Net earned premiums from our small employer group business decreased $8,717, or 8%, due to fewer small group insured lives, partially offset by premium rate increases.
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased $26,671, or 7%, to $380,164 for First Quarter 2013 from $406,835 for First Quarter 2012. Policyholder benefits decreased $26,989, or 9%, while the benefit loss ratio decreased to 72.6% from 74.2%. The decrease in policyholder benefits was primarily attributable to a decline in business volume. The decrease in the benefit loss ratio reflects a growing proportion of business not subject to the Affordable Care Act with lower loss ratios. Selling, underwriting and general expenses stayed relatively consistent.
47
Assurant Employee Benefits
Overview
The tables below present information regarding Assurant Employee Benefits segment results of operations:
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net earned premiums |
$ | 251,940 | $ | 258,440 | ||||
Net investment income |
30,138 | 31,933 | ||||||
Fees and other income |
5,629 | 7,008 | ||||||
|
|
|
|
|||||
Total revenues |
287,707 | 297,381 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Policyholder benefits |
183,406 | 188,356 | ||||||
Selling, underwriting and general expenses |
95,112 | 95,349 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
278,518 | 283,705 | ||||||
|
|
|
|
|||||
Segment income before provision for income taxes |
9,189 | 13,676 | ||||||
Provision for income taxes |
3,106 | 4,612 | ||||||
|
|
|
|
|||||
Segment net income |
$ | 6,083 | $ | 9,064 | ||||
|
|
|
|
|||||
Net earned premiums: |
||||||||
Group dental |
$ | 96,034 | $ | 99,467 | ||||
Group disability |
100,186 | 105,839 | ||||||
Group life |
47,629 | 48,838 | ||||||
Group vision and supplemental products |
8,091 | 4,296 | ||||||
|
|
|
|
|||||
Total |
$ | 251,940 | $ | 258,440 | ||||
|
|
|
|
|||||
Ratios: |
||||||||
Loss ratio (1) |
72.8 | % | 72.9 | % | ||||
Expense ratio (2) |
36.9 | % | 35.9 | % |
(1) | The loss ratio is equal to policyholder benefits divided by net earned premiums. |
(2) | The expense ratio is equal to selling, underwriting and general expenses divided by net earned premiums and fees and other income. |
For The Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net Income
Segment net income decreased 33% to $6,083 for First Quarter 2013 from $9,064 for First Quarter 2012. First Quarter 2013 net investment income declined compared to First Quarter 2012 due to lower invested assets and lower investment yields. Additionally, First Quarter 2013 results were adversely affected by a previously disclosed decrease in new long-term disability claims reserve discount rate. First Quarter 2013 favorable dental results were offset by unfavorable life mortality experience.
Total Revenues
Total revenues decreased 3% to $287,707 for First Quarter 2013 from $297,381 for First Quarter 2012. First Quarter 2013 net earned premiums decreased $6,500 or 3%. The decrease in net earned premiums was driven primarily by the previously disclosed loss of two assumed disability clients partially offset by premium growth in voluntary products. Net investment income decreased 6% or $1,795 driven by lower average invested assets and lower investment yields.
48
Total Benefits, Losses and Expenses
Total benefits, losses and expenses decreased 2% to $278,518 for First Quarter 2013 from $283,705 for First Quarter 2012. Policyholder benefits declined $4,950, or 3% to $183,406 in First Quarter 2013 from $188,356 in First Quarter 2012. The decline is primarily due to lower net earned premiums. Favorable dental loss experience was offset by unfavorable life loss experience. Disability results include a previously disclosed decrease in the reserve discount rate for new long-term disability claims. Although selling, underwriting and general expenses remained relatively flat, the expense ratio increased to 36.9% from 35.9% attributable to the decrease in net earned premiums.
49
Assurant Corporate & Other
The table below presents information regarding the Corporate & Other segments results of operations:
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Revenues: |
||||||||
Net investment income |
$ | 5,509 | $ | 5,222 | ||||
Net realized gains on investments |
13,038 | 7,544 | ||||||
Amortization of deferred gain on disposal of businesses |
4,092 | 4,621 | ||||||
Fees and other income |
56 | 61 | ||||||
|
|
|
|
|||||
Total revenues |
22,695 | 17,448 | ||||||
|
|
|
|
|||||
Benefits, losses and expenses: |
||||||||
Selling, underwriting and general expenses |
27,090 | 21,953 | ||||||
Interest expense |
15,078 | 15,076 | ||||||
|
|
|
|
|||||
Total benefits, losses and expenses |
42,168 | 37,029 | ||||||
|
|
|
|
|||||
Segment loss before benefit for income taxes |
(19,473 | ) | (19,581 | ) | ||||
Benefit for income taxes |
(7,362 | ) | (5,758 | ) | ||||
|
|
|
|
|||||
Segment net loss |
$ | (12,111 | ) | $ | (13,823 | ) | ||
|
|
|
|
For The Three Months Ended March 31, 2013 Compared to The Three Months Ended March 31, 2012
Net Loss
Segment net loss decreased $1,712, or 12%, to $12,111 for First Quarter 2013 compared with $13,823 for First Quarter 2012. The decrease is primarily attributable to changes in tax liabilities which resulted in a higher income tax benefit.
Total Revenues
Total revenues increased $5,247, or 30%, to $22,695 for First Quarter 2013 compared with $17,448 for First Quarter 2012 primarily due to increased net realized gains on investments.
Total Benefits, Losses and Expenses
Total expenses increased $5,139, or 14%, to $42,168 for First Quarter 2013 compared with $37,029 for First Quarter 2012. This increase is mainly due to increased pension-related expenses and new investments in areas targeted for growth.
50
Investments
The Company had total investments of $14,882,768 and $14,976,318 as of March 31, 2013 and December 31, 2012, respectively. For more information on our investments see Note 4 to the Notes to Consolidated Financial Statements included elsewhere in this report.
The following table shows the credit quality of our fixed maturity securities portfolio as of the dates indicated:
As of | ||||||||||||||||
Fixed Maturity Securities by Credit Quality (Fair Value) |
March 31, 2013 | December 31, 2012 | ||||||||||||||
Aaa / Aa / A |
$ | 7,767,518 | 63.9 | % | $ | 7,704,911 | 63.2 | % | ||||||||
Baa |
3,618,493 | 29.8 | % | 3,730,850 | 30.7 | % | ||||||||||
Ba |
493,857 | 4.1 | % | 472,773 | 3.9 | % | ||||||||||
B and lower |
263,932 | 2.2 | % | 263,104 | 2.2 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 12,143,800 | 100.0 | % | $ | 12,171,638 | 100.0 | % | ||||||||
|
|
|
|
|
|
|
|
Major categories of net investment income were as follows:
Three Months
Ended March 31, |
||||||||
2013 | 2012 | |||||||
Fixed maturity securities |
$ | 134,328 | $ | 141,182 | ||||
Equity securities |
6,887 | 5,872 | ||||||
Commercial mortgage loans on real estate |
19,337 | 19,663 | ||||||
Policy loans |
993 | 798 | ||||||
Short-term investments |
441 | 1,377 | ||||||
Other investments |
6,099 | 5,074 | ||||||
Cash and cash equivalents |
3,916 | 3,901 | ||||||
|
|
|
|
|||||
Total investment income |
172,001 | 177,867 | ||||||
Investment expenses |
(6,016 | ) | (5,572 | ) | ||||
|
|
|
|
|||||
Net investment income |
$ | 165,985 | $ | 172,295 | ||||
|
|
|
|
Net investment income declined $6,310, or 4%, to $165,985 for First Quarter 2013 compared with $172,295 for First Quarter 2012. The decrease in primarily due to lower investment yields.
As of March 31, 2013, the Company owned $230,372 of securities guaranteed by financial guarantee insurance companies. Included in this amount was $215,655 of municipal securities, with a credit rating of A+ both with and without the guarantee.
The Company has exposure to sub-prime and related mortgages within our fixed maturity securities portfolio. At March 31, 2013, approximately 3.4% of our residential mortgage-backed holdings had exposure to sub-prime mortgage collateral. This represented approximately 0.2% of the total fixed income portfolio and 1.2% of the total unrealized gain position. Of the securities with sub-prime exposure, approximately 14.1% are rated as investment grade. All residential mortgage-backed securities, including those with sub-prime exposure, are reviewed as part of the ongoing other-than-temporary impairment monitoring process.
Collateralized Transactions
The Company engages in transactions in which fixed maturity securities, primarily bonds issued by the U.S. government, government agencies and authorities, and U.S. corporations, are loaned to selected broker/dealers. Collateral, greater than or equal to 102% of the fair value of the securities lent, plus accrued interest, is received in the form of cash and cash equivalents held by a custodian bank for the benefit of the Company. The use of cash collateral received is unrestricted. The Company reinvests the cash collateral received, generally in investments of high credit quality that are designated as available-for-sale. The Company monitors the fair value of securities loaned and the collateral received, with additional collateral obtained, as necessary. The Company is subject to the risk of loss to the extent there is a loss on the re-investment of cash collateral.
51
As of March 31, 2013 and December 31, 2012, our collateral held under securities lending, of which its use is unrestricted, was $94,629 and $94,729, respectively, and is included in the consolidated balance sheets under the collateral held/pledged under securities agreements. Our liability to the borrower for collateral received was $94,611 and $94,714, respectively, and is included in the consolidated balance sheets under the obligation under securities agreements. The difference between the collateral held and obligations under securities lending is recorded as an unrealized gain and is included as part of AOCI. The Company includes the available-for-sale investments purchased with the cash collateral in its evaluation of other-than-temporary impairments.
Cash proceeds that the Company receives as collateral for the securities it lends and subsequent repayment of the cash are regarded by the Company as cash flows from financing activities, since the cash received is considered a borrowing. Since the Company reinvests the cash collateral generally in investments that are designated as available-for-sale, the reinvestment is presented as cash flows from investing activities.
Liquidity and Capital Resources
Regulatory Requirements
Assurant, Inc. is a holding company and, as such, has limited direct operations of its own. Our holding companys assets consist primarily of the capital stock of our subsidiaries. Accordingly, our holding companys future cash flows depend upon the availability of dividends and other statutorily permissible payments from our subsidiaries, such as payments under our tax allocation agreement and under management agreements with our subsidiaries. The ability to pay such dividends and to make such other payments will be limited by applicable laws and regulations of the states in which our subsidiaries are domiciled, which subject our subsidiaries to significant regulatory restrictions. The dividend requirements and regulations vary from state to state and by type of insurance provided by the applicable subsidiary. These laws and regulations require, among other things, our insurance subsidiaries to maintain minimum solvency requirements and limit the amount of dividends these subsidiaries can pay to the holding company. For further information on pending amendments to state insurance holding company laws, including the NAICs Solvency Modernization Initiative, see Item 1ARisk FactorsRisks Related to Our Company Changes in regulation may reduce our profitability and limit our growth in our 2012 Annual Report on Form 10-K. Along with solvency regulations, the primary driver in determining the amount of capital used for dividends is the level of capital needed to maintain desired financial strength ratings from A.M. Best.
It is possible that regulators or rating agencies could become more conservative in their methodology and criteria, including increasing capital requirements for our insurance subsidiaries which, in turn, could negatively affect our capital resources. On February 24, 2012, Moodys Investor Services (Moodys) affirmed Assurant Inc.s Senior Debt rating of Baa2, but changed the outlook on this rating to stable from negative. In addition, Moodys affirmed the financial strength ratings of Assurants primary life and health insurance subsidiaries at A3 but changed the outlook on the ratings of two of our life and health insurance subsidiaries to stable from negative. A negative outlook remains on the ratings of Assurants two other rated life and health subsidiaries due to concerns about the impact of the Affordable Care Act. On December 11, 2012, Standard and Poors (S&P) revised the outlook on the financial strength ratings of American Bankers Life Assurance Company of Florida and American Memorial Life Insurance Company from stable to positive. For further information on our ratings and the risks of ratings downgrades, see Item 1Business and Item 1ARisk FactorsRisks Related to Our CompanyA.M. Best, Moodys and S&P rate the financial strength of our insurance company subsidiaries, and a decline in these ratings could affect our standing in the insurance industry and cause our sales and earnings to decrease in our 2012 Annual Report on Form 10-K. For 2013, the maximum amount of dividends our U.S. domiciled insurance subsidiaries could pay, under applicable laws and regulations without prior regulatory approval, is approximately $524,000. During First Quarter 2013, we received dividends or returns of capital, net of infusions, of $21,400 from our subsidiaries. We expect 2013 dividends from the operating segments to approximate their earnings subject to the growth of the businesses, rating agency and regulatory capital requirements and investment performance.
Liquidity
As of March 31, 2013, we had $880,433 in holding company capital, excluding $500,000 from the March 2013 debt offering which will be used to repay debt maturing in February 2014. We use the term holding company capital to represent cash and other liquid marketable securities held at Assurant, Inc., out of a total of $1,066,055, that we are not otherwise holding for a specific purpose as of the balance sheet date, but can be used for stock repurchases, stockholder dividends, acquisitions, and other corporate purposes. $250,000 of the $880,433 of holding company capital is intended to serve as a buffer against remote risks (such as large-scale hurricanes). Dividends or returns of capital, net of infusions, made to the holding company from its operating companies were $21,400 and $581,908 for First Quarter 2013 and the year ended December 31, 2012, respectively. We use these cash inflows primarily to pay expenses, to make interest payments on indebtedness, to make dividend payments to our stockholders, to make subsidiary capital contributions, to fund acquisitions and to repurchase our outstanding shares.
52
In addition to paying expenses and making interest payments on indebtedness, our capital management strategy provides for several uses for the cash generated by our subsidiaries, including without limitation, returning capital to shareholders through share repurchases and dividends, investing in our businesses to support growth in targeted areas, and making prudent and opportunistic acquisitions. We made share repurchases and paid dividends to our stockholders of $43,356 and $472,103 during First Quarter 2013 and the year ended December 31, 2012, respectively.
The primary sources of funds for our subsidiaries consist of premiums and fees collected, proceeds from the sales and maturity of investments and net investment income. Cash is primarily used to pay insurance claims, agent commissions, operating expenses and taxes. We generally invest our subsidiaries excess funds in order to generate investment income.
We conduct periodic asset liability studies to measure the duration of our insurance liabilities, to develop optimal asset portfolio maturity structures for our significant lines of business and ultimately to assess that cash flows are sufficient to meet the timing of cash needs. These studies are conducted in accordance with formal company-wide Asset Liability Management (ALM) guidelines.
To complete a study for a particular line of business, models are developed to project asset and liability cash flows and balance sheet items under a large, varied set of plausible economic scenarios. These models consider many factors including the current investment portfolio, the required capital for the related assets and liabilities, our tax position and projected cash flows from both existing and projected new business.
Alternative asset portfolio structures are analyzed for significant lines of business. An investment portfolio maturity structure is then selected from these profiles given our return hurdle and risk preference. Sensitivity testing of significant liability assumptions and new business projections is also performed.
Our liabilities generally have limited policyholder optionality, which means that the timing of payments is relatively insensitive to the interest rate environment. In addition, our investment portfolio is largely comprised of highly liquid fixed maturity securities with a sufficient component of such securities invested that are near maturity which may be sold with minimal risk of loss to meet cash needs. Therefore, we believe we have limited exposure to disintermediation risk.
Generally, our subsidiaries premiums, fees and investment income, along with planned asset sales and maturities, provide sufficient cash to pay claims and expenses. However, there may be instances when unexpected cash needs arise in excess of that available from usual operating sources. In such instances, we have several options to raise needed funds, including selling assets from the subsidiaries investment portfolios, using holding company cash (if available), issuing commercial paper, or drawing funds from our revolving credit facility. In addition, we have filed an automatically effective shelf registration statement on Form S-3 with the SEC. This registration statement allows us to issue equity, debt or other types of securities through one or more methods of distribution. The terms of any offering would be established at the time of the offering, subject to market conditions. If we decide to make an offering of securities, we will consider the nature of the cash requirement as well as the cost of capital in determining what type of securities we may offer.
We paid dividends of $0.21 per common share on March 11, 2013 to stockholders of record as of February 25, 2013. Any determination to pay future dividends will be at the discretion of our Board of Directors and will be dependent upon: our subsidiaries payment of dividends and/or other statutorily permissible payments to us; our results of operations and cash flows; our financial position and capital requirements; general business conditions; any legal, tax, regulatory and contractual restrictions on the payment of dividends; and any other factors our Board of Directors deems relevant.
On May 14, 2012, our Board of Directors authorized the Company to repurchase up to an additional $600,000 of its outstanding common stock. As of December 31, 2012, there was $502,900 remaining under the total repurchase authorization. During the three months ended March 31, 2013, we repurchased 600,000 shares of our outstanding common stock at a cost of $26,554, exclusive of commissions. As of March 31, 2013, $476,345 remained under the total repurchase authorization. The timing and the amount of future repurchases will depend on market conditions and other factors.
Management believes the Company will have sufficient liquidity to satisfy its needs over the next twelve months, including the ability to pay interest on our Senior Notes and dividends on our common shares.
Retirement and Other Employee Benefits
Our qualified pension benefits plan (the Plan) was under-funded by $77,533 and $107,666 (based on the fair value of Plan assets compared to the projected benefit obligation) on a GAAP basis at March 31, 2013 and December 31, 2012, respectively. This equates to a 90% and 87% funded status at March 31, 2013 and December 31, 2012, respectively. The change in under-funded projected benefit obligation status is mainly due to an increase in the discount rate used to determine the projected benefit obligation and favorable investment returns.
53
In prior years we established a funding policy in which service cost plus 15% of qualified plan deficit will be contributed annually. During First Quarter 2013, we contributed $12,500 in cash to the Plan. Additional cash, up to $37,500, is expected to be contributed to the Plan over the remainder of 2013.
Commercial Paper Program
Our commercial paper program requires us to maintain liquidity facilities either in an available amount equal to any outstanding notes from the program or in an amount sufficient to maintain the ratings assigned to the notes issued from the program. Our commercial paper is rated AMB-2 by A.M. Best, P-2 by Moodys and A2 by S&P. Our subsidiaries do not maintain commercial paper or other borrowing facilities. This program is currently backed up by a $350,000 senior revolving credit facility, of which $328,958 was available at March 31, 2013, due to outstanding letters of credit.
On September 21, 2011, we entered into a four-year unsecured $350,000 revolving credit agreement (2011 Credit Facility) with a syndicate of banks arranged by JP Morgan Chase Bank, N.A. and Bank of America, N.A. The 2011 Credit Facility provides for revolving loans and the issuance of multi-bank, syndicated letters of credit and/or letters of credit from a sole issuing bank in an aggregate amount of $350,000 and is available until September 2015, provided we are in compliance with all covenants. The 2011 Credit Facility has a sublimit for letters of credit issued thereunder of $50,000. The proceeds of these loans may be used for our commercial paper program or for general corporate purposes. The Company may increase the total amount available under the 2011 Credit Facility to $525,000 subject to certain conditions. No bank is obligated to provide commitments above their current share of the $350,000 facility.
We did not use the commercial paper program during the three months ended March 31, 2013 or 2012, and there were no amounts outstanding relating to the commercial paper program at March 31, 2013 and December 31, 2012. The Company made no borrowings using the 2011 Credit Facility and no loans are outstanding at March 31, 2013. We had $21,042 of letters of credit outstanding under the 2011 Credit Facility as of March 31, 2013.
The 2011 Credit Facility contains restrictive covenants and requires that the Company maintain certain specified minimum ratios and thresholds. Among others, these covenants include maintaining a maximum debt to capitalization ratio and a minimum consolidated adjusted net worth. At March 31, 2013, we were in compliance with all covenants, minimum ratios, and thresholds.
Senior Notes
On March 28, 2013, we completed an issuance of two series of senior notes with an aggregate principal amount of $700,000 (the 2013 Senior Notes). The first series is $350,000 in principal amount, bears interest at 2.50% per year and is payable in a single installment due March 15, 2018. The second series is $350,000 in principal amount, bears interest at 4.00% per year and is payable in a single installment due March 15, 2023.
The net proceeds from the sale of the 2013 Senior Notes was $698,093, which represents the principal amount less the discount before offering expenses. The Company intends to use the net proceeds of the 2013 Senior Notes offering for general corporate purposes, including to repay $500,000 of debt maturing in 2014.
In addition, we have two series of senior notes outstanding in an aggregate principal amount of $975,000 (the 2004 Senior Notes). The first series is $500,000 in principal amount, bears interest at 5.63% per year and is due February 15, 2014. The second series is $475,000 in principal amount, bears interest at 6.75% per year and is due February 15, 2034.
Interest on our 2004 Senior Notes is payable semi-annually on February 15 and August 15 of each year. The interest expense incurred related to the 2004 Senior Notes was $15,078 and $15,076 for the three months ended March 31, 2013 and 2012, respectively. There was $7,523 of accrued interest at March 31, 2013 and 2012, respectively. The 2004 Senior Notes are unsecured obligations and rank equally with all of our other senior unsecured indebtedness. The 2004 Senior Notes are not redeemable prior to maturity.
54
Cash Flows
We monitor cash flows at the consolidated, holding company and subsidiary levels. Cash flow forecasts at the consolidated and subsidiary levels are provided on a monthly basis, and we use trend and variance analyses to project future cash needs, making adjustments to the forecasts when needed.
The table below shows our recent net cash flows:
For the Three Months Ended March 31, |
||||||||
Net cash provided by (used in): |
2013 | 2012 | ||||||
Operating activities (1) |
$ | 43,560 | $ | 1,826 | ||||
Investing activities |
(18,511 | ) | 18,576 | |||||
Financing activities |
670,172 | (122,300 | ) | |||||
|
|
|
|
|||||
Net change in cash |
$ | 695,221 | $ | (101,898 | ) | |||
|
|
|
|
(1) | Includes effect of exchange rate changes on cash and cash equivalents. |
We typically generate operating cash inflows from premiums collected from our insurance products and income received from our investments while outflows consist of policy acquisition costs, benefits paid, and operating expenses. These net cash flows are then invested to support the obligations of our insurance products and required capital supporting these products. Our cash flows from operating activities are affected by the timing of premiums, fees, and investment income received and expenses paid.
Net cash provided by operating activities was $43,560 and $1,826 for First Quarter 2013 and First Quarter 2012, respectively. The increase in cash provided by operating activities was primarily due to increased net written premiums in our Assurant Solutions segment, partially offset by increased catastrophe loss payments and a $14,000 settlement with the New York Department of Financial Services in our Assurant Specialty Property segment.
Net cash (used in) provided by investing activities was $(18,511) and $18,576 for First Quarter 2013 and First Quarter 2012, respectively. The decrease in investing activities was mainly due to increased purchases of fixed maturity securities and other invested assets.
Net cash provided by (used in) financing activities was $670,172 and $(122,300) for First Quarter 2013 and First Quarter 2012, respectively. The increase in financing activities was primarily due to the issuance of two series of senior notes on March 28, 2013. The Company received proceeds of $698,093 from this transaction, which represents the principal amount less the discount before offering expenses. In addition, the Company repurchased $97,012 less of its common stock during First Quarter 2013 compared with First Quarter 2012.
The table below shows our cash outflows for interest and dividends for the periods indicated:
For the Three Months Ended March 31, |
||||||||
2013 | 2012 | |||||||
Interest paid on debt |
$ | 30,094 | $ | 30,094 | ||||
Common stock dividends |
16,789 | 15,941 | ||||||
|
|
|
|
|||||
Total |
$ | 46,883 | $ | 46,035 | ||||
|
|
|
|
Letters of Credit
In the normal course of business, we issue letters of credit primarily to support reinsurance arrangements. These letters of credit are supported by commitments with financial institutions. We had $21,042 and $19,760 of letters of credit outstanding as of March 31, 2013 and December 31, 2012.
Recent Accounting Pronouncements
For a discussion of recent accounting pronouncements, see Note 3 to the Notes to Consolidated Financial Statements.
55
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Our 2012 Annual Report on Form 10-K described our Quantitative and Qualitative Disclosures About Market Risk. There were no material changes to the assumptions or risks during First Quarter 2013.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Companys Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Companys disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the Exchange Act) as of March 31, 2013. Based on that review, the Companys Chief Executive Officer and Chief Financial Officer have concluded that the Companys disclosure controls and procedures are effective to provide reasonable assurance that information the Company is required to disclose in its reports under the Exchange Act is recorded, processed, summarized and reported accurately including, without limitation, ensuring that such information is accumulated and communicated to the Companys management as appropriate to allow timely decisions regarding required disclosure.
Internal Control over Financial Reporting
During the quarter ended March 31, 2013, we made no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
56
OTHER INFORMATION
The Company is involved in a variety of legal and regulatory actions in the ordinary course relating to its current and past business operations, both as a defendant and as a plaintiff, and may from time to time become involved in other such actions. See Note 13 to the Notes to Consolidated Financial Statements for a description of certain matters, which description is incorporated herein by reference. Although the Company cannot predict the outcome of any pending or future litigation, examination or investigation, it is possible that the outcome of such matters could have a material adverse effect on the Companys consolidated results of operations or cash flows for an individual reporting period. However, based on currently available information, management does not believe that any pending matter is likely to have a material adverse effect, individually or in the aggregate, on the Companys financial condition.
Certain factors may have a material adverse effect on our business, financial condition and results of operations and you should carefully consider them. It is not possible to predict or identify all such factors. For discussion of our potential risks or uncertainties, please refer to Item 1ARisk Factors included in our 2012 Annual Report on Form 10-K. Except as set forth in the following updated risk factor, there have been no material changes to the risk factors disclosed in our 2012 Annual Report on Form 10-K.
Our business is subject to risks related to litigation and regulatory actions.
From time to time, we may be subject to a variety of legal and regulatory actions relating to our current and past business operations, including, but not limited to:
| actions by regulatory authorities that may challenge our ability to increase or maintain our premium rates, require us to reduce premium rates, impose fine or penalties and/or result in other fees; |
| disputes regarding our lender-placed insurance products including those relating to rates, agent compensation, consumer disclosure, continuous coverage requirements, loan tracking services and other services that we provide to mortgage servicers; |
| disputes over coverage or claims adjudication including, but not limited to, pre-existing conditions in individual medical contracts and rescissions of policies; |
| disputes over our treatment of claims, in which states or insureds may allege that we failed to make required payments or to meet prescribed deadlines for adjudicating claims; |
| disputes regarding sales practices, disclosures, premium refunds, licensing, regulatory compliance, underwriting and compensation arrangements; |
| disputes with agents, brokers or network providers over compensation and termination of contracts and related claims; |
| disputes alleging bundling of credit insurance and warranty products with other products provided by financial institutions; |
| disputes with tax and insurance authorities regarding our tax liabilities; |
| disputes relating to customers claims that the customer was not aware of the full cost or existence of the insurance or limitations on insurance coverage; and |
| industry-wide investigations regarding business practices including, but not limited to, the use and the marketing of certain types of insurance policies or certificates of insurance. |
As previously disclosed, on March 21, 2013, the Company, ASIC and ABIC reached an agreement with the NYDFS regarding the Companys lender-placed insurance business in the State of New York. For additional detail on this settlement, please see Assurant Specialty Propertys results of operations section in Item 2Managements Discussion and Analysis of Financial Condition and Results of Operations of this report, above.
In addition, as previously disclosed, ASIC reached an agreement with the California Department of Insurance to reduce premium rates for lender-placed hazard insurance products by 30.5%. The rate reduction reflects factors specific to California such as continued favorable loss experience in the state and different assumptions about future experience compared to our previous rate filing. The new rates in California began to apply to policies newly issued or renewed with effective dates on or after January 19,
57
2013. ASIC recorded approximately $111,000 of net earned premiums ($154,000 of gross written premium) for full year 2012 for the type of policies subject to the rate reduction. The actual effect of the California rate decrease on the Companys net earned premiums and net income over the course of 2013 and beyond will depend on a variety of factors, including the Companys mix of lender-placed insurance products, lapse rates, rate and timing of renewals, placement rates, changes in client contracts and actual expenses incurred.
As previously disclosed, Assurant Specialty Propertys business strategy has been to pursue long-term growth in lender-placed homeowners insurance and adjacent markets with similar characteristics, such as lender-placed flood insurance and lender-placed mobile home insurance. Lender-placed insurance products accounted for approximately 70% and 71% of Assurant Specialty Propertys net earned premiums for the first quarter of 2013 and full year 2012, respectively. The approximate corresponding contributions to segment net income in these periods were 81% and 90%, respectively. The portion of total segment net income attributable to lender-placed products may vary substantially over time depending on the frequency, severity and location of catastrophic losses, the cost of catastrophe reinsurance and reinstatement coverage, the variability of claim processing costs and client acquisition costs, and other factors. In addition, we expect placement rates for these products to decline.
The Company files rates with the state departments of insurance in the ordinary course of business. As previously disclosed, in addition to this routine correspondence, the Company has been engaged in discussions and proceedings with certain state regulators regarding our lender-placed insurance business. Because assumptions used in rate filings vary by state as a result of differing regulatory requirements, expected loss experience and catastrophe exposure, the results of such reviews may vary widely. It is possible that other state departments of insurance and regulatory authorities may choose to initiate or continue to review the appropriateness of the Companys premium rates for its lender-placed insurance products. If in the aggregate further reviews by state departments of insurance lead to significant decreases in premium rates for the Companys lender-placed insurance products, our results of operations could be materially adversely affected.
Unfavorable outcomes in litigation or regulatory proceedings, or significant problems in our relationships with regulators, could materially adversely affect our results of operations and financial condition, our reputation, our ratings, and our ability to continue to do business. They could also expose us to further investigations or litigations. In addition, certain of our clients in the mortgage and credit card and banking industries are the subject of various regulatory investigations and/or litigation regarding mortgage lending practices, credit insurance, debt-deferment and debt cancelation products, and the sale of ancillary products, which could indirectly affect our businesses.
58
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Repurchase of Equity Securities:
Period in 2013 |
Total Number of Shares Purchased |
Average Price Paid Per Share |
Total Number
of Shares Purchased as Part of Publicly Announced Programs (1) |
Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs (1) |
||||||||||||
January 1-31 |
0 | $ | 0.00 | 0 | $ | 502,900 | ||||||||||
February 1-28 |
0 | 0.00 | 0 | 502,900 | ||||||||||||
March 1-31 |
600,000 | 44.28 | 600,000 | 476,345 | ||||||||||||
|
|
|
|
|||||||||||||
Total |
600,000 | $ | 44.28 | 600,000 | $ | 476,345 | ||||||||||
|
|
|
|
(1) | Shares purchased pursuant to the May 14, 2012 publicly announced share repurchase authorization of up to $600,000 of outstanding common stock. |
59
Pursuant to the rules and regulations of the SEC, the Company has filed or incorporated by reference certain agreements as exhibits to this quarterly report on Form 10-Q. These agreements may contain representations and warranties by the parties. These representations and warranties have been made solely for the benefit of the other party or parties to such agreements and (i) may have been qualified by disclosures made to such other party or parties, (ii) were made only as of the date of such agreements or such other date(s) as may be specified in such agreements and are subject to more recent developments, which may not be fully reflected in the Companys public disclosure, (iii) may reflect the allocation of risk among the parties to such agreements and (iv) may apply materiality standards different from what may be viewed as material to investors. Accordingly, these representations and warranties may not describe the Companys actual state of affairs at the date hereof and should not be relied upon.
The following exhibits either (a) are filed with this report or (b) have previously been filed with the SEC and are incorporated herein by reference to those prior filings. Exhibits are available upon request at the investor relations section of our website at www.assurant.com. Our website is not a part of this report and is not incorporated by reference in this report.
12.1 | Computation of Ratio of Consolidated Earnings to Fixed Charges. | |
31.1 | Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer. | |
31.2 | Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer. | |
32.1 | Certification of Chief Executive Officer of Assurant, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2 | Certification of Chief Financial Officer of Assurant, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101 | The following materials from the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statement of Changes in Stockholders Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements. |
60
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ASSURANT, INC. | ||||
Date: May 1, 2013 |
By: | /s/ ROBERT B. POLLOCK | ||
| ||||
Name: | Robert B. Pollock | |||
Title: | President and Chief Executive Officer | |||
Date: May 1, 2013 |
By: | /s/ MICHAEL J. PENINGER | ||
| ||||
Name: | Michael J. Peninger | |||
Title: | Executive Vice President and Chief Financial Officer |
61
EXHIBIT 12.1
ASSURANT, INC.
COMPUTATION OF RATIO OF CONSOLIDATED EARNINGS TO FIXED CHARGES
(in millions of U.S. dollars except for ratio amounts)
2008 | 2009 | 2010 | 2011 | 2012 | March 31, 2013 | |||||||||||||||||||
Income before income taxes |
$ | 563.6 | $ | 714.3 | $ | 606.5 | $ | 706.2 | $ | 757.8 | $ | 206.4 | ||||||||||||
Fixed charges |
73.5 | 74.6 | 73.8 | 70.2 | 70.2 | 17.3 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income as adjusted |
$ | 637.1 | $ | 788.9 | $ | 680.3 | $ | 776.4 | $ | 828.0 | $ | 223.7 | ||||||||||||
Fixed charges: |
||||||||||||||||||||||||
Interest expense, including discount amortization and preferred stock dividends (1) |
$ | 61.0 | $ | 60.7 | $ | 60.6 | $ | 60.4 | $ | 60.3 | $ | 15.1 | ||||||||||||
Portion of rents representative of an appropriate interest factor |
12.5 | 13.9 | 13.2 | 9.8 | 9.9 | 2.2 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total fixed charges |
$ | 73.5 | $ | 74.6 | $ | 73.8 | $ | 70.2 | $ | 70.2 | $ | 17.3 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ratio of consolidated earnings to fixed charges |
8.67 | 10.58 | 9.22 | 11.06 | 11.79 | 12.93 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Preferred stock issued is recorded as a liability, thus the corresponding dividend is recorded as interest expense. |
EXHIBIT 31.1
CERTIFICATIONS
I, Robert B. Pollock, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Assurant, Inc. for the period ended March 31, 2013;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: May 1, 2013
/s/ Robert B. Pollock |
Robert B. Pollock President and Chief Executive Officer |
EXHIBIT 31.2
CERTIFICATIONS
I, Michael J. Peninger, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Assurant, Inc. for the period ended March 31, 2013;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: May 1, 2013
/s/ Michael J. Peninger |
Michael J. Peninger Executive Vice President and Chief Financial Officer |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF
ASSURANT, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
§ 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Assurant, Inc. (the Company) on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robert B. Pollock, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 1, 2013
/s/ Robert B. Pollock |
Robert B. Pollock President and Chief Executive Officer |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER OF
ASSURANT, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
§ 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Assurant, Inc. (the Company) on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael J. Peninger, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 1, 2013
/s/ Michael J. Peninger |
Michael J. Peninger Executive Vice President and Chief Financial Officer |
Commitments And Contingencies (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified |
0 Months Ended | ||
---|---|---|---|
Mar. 21, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
|
Commitments And Contingencies [Abstract] | |||
Letters of credit outstanding | $ 21,042 | $ 19,760 | |
Litigation Settlement, Amount | $ 14,000 |
Stock Repurchase (Shares Repurchased) (Details) (USD $)
|
1 Months Ended | 3 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2013
|
Feb. 28, 2013
|
Jan. 31, 2013
|
Mar. 31, 2013
|
|
Stock Repurchase [Abstract] | ||||
Number of Shares Purchased | 600,000 | 0 | 0 | 600,000 |
Average Price Paid Per Share | $ 44.28 | $ 0.00 | $ 0.00 | $ 44.28 |
Total Number of Shares Purchased as Part of Publicly Announced Programs | 600,000 | 0 | 0 | 600,000 |
Income Taxes (Narrative) (Details) (Compensation Expenses [Member], USD $)
In Thousands, unless otherwise specified |
3 Months Ended |
---|---|
Mar. 31, 2013
item
|
|
Compensation Expenses [Member]
|
|
Income Tax [Line Items] | |
Income tax expense | $ 10,205 |
Change in effective tax rate, basis points | 490 |
Stock Based Compensation (Narrative) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
1 Months Ended | 3 Months Ended | 1 Months Ended | 3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2008
Long-Term Incentive Plan [Member]
|
Dec. 31, 2004
Long-Term Incentive Plan [Member]
|
May 31, 2010
Long-Term Equity Incentive Plan [Member]
|
May 31, 2008
Long-Term Equity Incentive Plan [Member]
|
Mar. 31, 2013
Restricted Stock Units [Member]
|
Mar. 31, 2012
Restricted Stock Units [Member]
|
Mar. 31, 2013
Performance Share Units [Member]
|
Mar. 31, 2012
Performance Share Units [Member]
|
Jan. 31, 2013
Employee Stock Purchase Plan [Member]
|
Jan. 31, 2012
Employee Stock Purchase Plan [Member]
|
Mar. 31, 2013
Employee Stock Purchase Plan [Member]
|
Mar. 31, 2012
Employee Stock Purchase Plan [Member]
|
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||||||||
Revenues benchmark for performance payout | 1,000,000 | |||||||||||
Company's common stock authorized to employees | 10,000,000 | 5,300,000 | 3,400,000 | 5,000,000 | ||||||||
RSU vesting terms for employees and directors | 0.33 | |||||||||||
Vesting period (in years) | 3 years | |||||||||||
Percentage of payout level minimum | 0.00% | |||||||||||
Percentage of payout level maximum | 150.00% | |||||||||||
Percentage of payout level target | 100.00% | |||||||||||
Compensation expense | $ 5,552 | $ 5,082 | $ 1,942 | $ 3,474 | $ 249 | $ 379 | ||||||
Compensation expenses income tax benefit | 1,932 | 1,781 | 668 | 1,218 | ||||||||
Weighted average grant date fair value | $ 43.74 | $ 41.68 | $ 44.22 | $ 41.68 | ||||||||
Unrecognized compensation cost | 31,476 | 26,933 | ||||||||||
Unrecognized compensation cost expected to be recognized over a weighted-average period (in years) | 1 year 7 months 2 days | 11 months 27 days | ||||||||||
Fair value of stock vested during the period | $ 17,672 | $ 18,517 | ||||||||||
Common shares issued | 107,535 | 103,243 | ||||||||||
Purchase shares at discount | 10.00% | |||||||||||
Common shares issued under discount price under this plan | $ 31.23 | $ 32.98 | ||||||||||
Stock units granted | 0 | 431,908 | 457,281 | 408,808 | 407,506 |
Investments (Proceeds From Sales Of Available-For-Sale Securities And The Gross Realized Gains And Gross Realized Losses) (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Investments [Abstract] | ||
Proceeds from sales | $ 776,670 | $ 468,591 |
Gross realized gains | 17,266 | 15,532 |
Gross realized losses | $ 5,205 | $ 6,569 |
Fair Value Disclosures (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value For Assets And Liabilities Measured At Fair Value On A Recurring Basis |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Change in Balance Sheet Carrying Value Associated with Level 3 Financial Assets and Liabilities Carried at Fair Value |
Transfers are primarily attributable to changes in the availability of observable market information and re-evaluation of the observability of pricing inputs.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying Value And Fair Value Of The Financial Instruments That Are Not Recognized Or Are Not Carried At Fair Value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Allowance For Doubtful Accounts For Reinsurance Recoverable |
|
Earnings Per Common Share (Net Income, Weighted Average Common Shares Used In Calculating Basic Earnings Per Common Share And Diluted EPS) (Details) (USD $)
|
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Earnings Per Share Basic And Diluted [Line Items] | ||
Net income | $ 117,780,000 | $ 163,260,000 |
Deduct dividends paid | (16,789,000.00) | (15,941,000.00) |
Undistributed earnings | $ 100,991,000.00 | $ 147,319,000.00 |
Weighted average shares outstanding used in basic earnings per share calculations | 79,984,576 | 88,772,845 |
Weighted average shares used in diluted earnings per share calculations | 80,946,649 | 90,069,097 |
Net income - Basic | $ 1.47 | $ 1.84 |
Net income - Diluted | $ 1.46 | $ 1.81 |
Distributed earnings - Basic | $ 0.21 | $ 0.18 |
Undistributed earnings - Basic | $ 1.26 | $ 1.66 |
Distributed earnings - Diluted | $ 0.21 | $ 0.18 |
Undistributed earnings - Diluted | $ 1.25 | $ 1.63 |
PSUs [Member]
|
||
Earnings Per Share Basic And Diluted [Line Items] | ||
Incremental common shares | 876,082 | 1,139,517 |
SARs [Member]
|
||
Earnings Per Share Basic And Diluted [Line Items] | ||
Incremental common shares | 73,515 | 156,735 |
ESPP [Member]
|
||
Earnings Per Share Basic And Diluted [Line Items] | ||
Incremental common shares | 12,476 | 0 |
Fair Value Disclosures (Schedule Of Allowance For Doubtful Accounts For Reinsurance Recoverable) (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended |
---|---|
Mar. 31, 2013
|
|
Fair Value Disclosures [Abstract] | |
Balance as of beginning-of-year | $ 10,633 |
Provision | 0 |
Other additions | 0 |
Direct write-downs charged against the allowance | 0 |
Balance as of the end-of-year | $ 10,633 |
Investments (Credit Quality Indicators For Commercial Mortgage Loans) (Details) (USD $)
In Thousands, unless otherwise specified |
Mar. 31, 2013
|
Dec. 31, 2012
|
---|---|---|
Financing Receivable, Recorded Investment [Line Items] | ||
Gross commercial mortgage loans | $ 1,297,000 | $ 1,318,679 |
% of Gross Mortgage Loans | 100.00% | 100.00% |
Debt-Service Coverage ratio | 1.84% | 1.85% |
Less valuation allowance | (6,997) | (6,997) |
Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total | 1,290,003 | 1,311,682 |
70% And Less [Member]
|
||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross commercial mortgage loans | 1,133,983 | 1,141,564 |
% of Gross Mortgage Loans | 87.40% | 86.60% |
Debt-Service Coverage ratio | 1.93% | 1.95% |
71 - 80% [Member]
|
||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross commercial mortgage loans | 92,634 | 103,152 |
% of Gross Mortgage Loans | 7.10% | 7.80% |
Debt-Service Coverage ratio | 1.35% | 1.30% |
81 - 95% [Member]
|
||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross commercial mortgage loans | 52,608 | 57,413 |
% of Gross Mortgage Loans | 4.10% | 4.30% |
Debt-Service Coverage ratio | 1.04% | 1.04% |
Greater Than 95% [Member]
|
||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross commercial mortgage loans | $ 17,775 | $ 16,550 |
% of Gross Mortgage Loans | 1.40% | 1.30% |
Debt-Service Coverage ratio | 1.05% | 1.02% |
Retirement And Other Employee Benefits (Components Of Net Periodic Benefit Cost) (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|||||
Pension Benefits [Member]
|
||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Service cost | $ 9,300 | $ 8,125 | ||||
Interest cost | 7,575 | 8,150 | ||||
Expected return on plan assets | (11,075) | (10,100) | ||||
Amortization of prior service cost | 0 | 25 | ||||
Amortization of net loss | 6,825 | 4,725 | ||||
Net periodic benefit cost | 12,625 | 10,925 | ||||
Nonqualified Pension Benefits [Member]
|
||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Service cost | 1,150 | [1] | 925 | [1] | ||
Interest cost | 1,200 | [1] | 1,350 | [1] | ||
Expected return on plan assets | 0 | [1] | 0 | [1] | ||
Amortization of prior service cost | 175 | [1] | 175 | [1] | ||
Amortization of net loss | 1,600 | [1] | 1,050 | [1] | ||
Net periodic benefit cost | 4,125 | [1] | 3,500 | [1] | ||
Retirement Health Benefits [Member]
|
||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Service cost | 850 | 700 | ||||
Interest cost | 825 | 875 | ||||
Expected return on plan assets | (700) | (775) | ||||
Amortization of prior service cost | (225) | (225) | ||||
Amortization of net loss | 0 | 0 | ||||
Net periodic benefit cost | $ 750 | $ 575 | ||||
|
Stock Repurchase (Narrative) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
0 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|---|
May 14, 2012
|
Mar. 31, 2013
|
Feb. 28, 2013
|
Jan. 31, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
|
Stock Repurchase [Abstract] | ||||||
Outstanding common stock repurchase authorized, value | $ 600,000 | |||||
Number of shares repurchased | 600,000 | 0 | 0 | 600,000 | ||
Shares repurchased, value | 26,554 | |||||
Value remaining under total repurchase authorization | $ 476,345 | $ 502,900 |
Nature Of Operations
|
3 Months Ended |
---|---|
Mar. 31, 2013
|
|
Nature Of Operations [Abstract] | |
Nature Of Operations | 1. Nature of Operations Assurant, Inc. (the “Company”) is a holding company whose subsidiaries provide specialized insurance products and related services in North America and select worldwide markets.
The Company is traded on the New York Stock Exchange under the symbol AIZ. Through its operating subsidiaries, the Company provides debt protection administration, credit-related insurance, warranties and service contracts, pre-funded funeral insurance, solar project insurance, lender-placed homeowners insurance, renters insurance and related products, manufactured housing homeowners insurance, individual health and small employer group health insurance, group dental insurance, group disability insurance and reinsurance, and group life insurance.
|
'0O:'1M;#L@8VAA
M '0O:'1M;#L@8VAA '0O:'1M;#L@8VAA
M '0O:'1M;#L@8VAA
M